<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Histochem Cell Biol</journal-id>
      <journal-title>Histochemistry and Cell Biology</journal-title>
      <issn pub-type="ppub">0948-6143</issn>
      <issn pub-type="epub">1432-119X</issn>
      <publisher>
        <publisher-name>Springer-Verlag</publisher-name>
        <publisher-loc>Berlin/Heidelberg</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18075753</article-id>
      <article-id pub-id-type="pmc">2228381</article-id>
      <article-id pub-id-type="publisher-id">366</article-id>
      <article-id pub-id-type="doi">10.1007/s00418-007-0366-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Protein quality control: the who&#x2019;s who, the where&#x2019;s and therapeutic escapes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Roth</surname>
            <given-names>J&#xFC;rgen</given-names>
          </name>
          <address>
            <phone>+41-44-2555090</phone>
            <fax>+41-44-2554407</fax>
            <email>jurgen.roth@bluewin.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yam</surname>
            <given-names>Gary Hin-Fai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fan</surname>
            <given-names>Jingyu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hirano</surname>
            <given-names>Kiyoko</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gaplovska-Kysela</surname>
            <given-names>Katarina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Le Fourn</surname>
            <given-names>Valerie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Guhl</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Santimaria</surname>
            <given-names>Roger</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Torossi</surname>
            <given-names>Tania</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ziak</surname>
            <given-names>Martin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Zuber</surname>
            <given-names>Christian</given-names>
          </name>
          <address>
            <phone>+41-44-2555090</phone>
            <fax>+41-44-2554407</fax>
            <email>zuber61@bluewin.ch</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Division of Cell and Molecular Pathology, Department of Pathology, University of Zurich, 8091 Zurich, Switzerland </aff>
        <aff id="Aff2"><label>2</label>Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, University Eye Centre, Mongkok, Kowloon Hong Kong </aff>
        <aff id="Aff3"><label>3</label>Department of Biophysics, Peking University Health Science Center, 100083 Beijing, P. R. China </aff>
        <aff id="Aff4"><label>4</label>The Noguchi Institute, 1-8-1 Kaga, Itabashi, Tokyo 173-0003 Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>12</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2008</year>
      </pub-date>
      <volume>129</volume>
      <issue>2</issue>
      <fpage>163</fpage>
      <lpage>177</lpage>
      <history>
        <date date-type="accepted">
          <day>28</day>
          <month>11</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer-Verlag 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>In cells the quality of newly synthesized proteins is monitored in regard to proper folding and correct assembly in the early secretory pathway, the cytosol and the nucleoplasm. Proteins recognized as non-native in the ER will be removed and degraded by a process termed ERAD. ERAD of aberrant proteins is accompanied by various changes of cellular organelles and results in protein folding diseases. This review focuses on how the immunocytochemical labeling and electron microscopic analyses have helped to disclose the in situ subcellular distribution pattern of some of the key machinery proteins of the cellular protein quality control, the organelle changes due to the presence of misfolded proteins, and the efficiency of synthetic chaperones to rescue disease-causing trafficking defects of aberrant proteins.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>ERAD</kwd>
        <kwd>Protein folding disease</kwd>
        <kwd>Glucosidase II</kwd>
        <kwd>Glucosyltransferase</kwd>
        <kwd>EDEM1</kwd>
        <kwd>Endomannosidase</kwd>
        <kwd>Chemical chaperones</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer-Verlag 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Folding and assembly of proteins and their function depend on each other. Like in industrial production lines, in cells the quality of newly synthesized proteins is monitored in regard to proper folding and correct assembly in the early secretory pathway, the cytosol and the nucleoplasm (Bennett et al. <xref ref-type="bibr" rid="CR10">2005</xref>; Bukau et al. <xref ref-type="bibr" rid="CR14">2006</xref>; Dobson <xref ref-type="bibr" rid="CR28">2003</xref>; Ellgaard and Helenius <xref ref-type="bibr" rid="CR32">2003</xref>; Park et al. <xref ref-type="bibr" rid="CR116">2007</xref>; Ravid et al. <xref ref-type="bibr" rid="CR128">2006</xref>; Roth <xref ref-type="bibr" rid="CR130">2002</xref>; Sitia and Braakman <xref ref-type="bibr" rid="CR144">2003</xref>; Zhang and Kaufman <xref ref-type="bibr" rid="CR180">2006</xref>). Protein quality control is a basic cellular phenomenon through which aberrant proteins become eliminated. Aberrant proteins can occur as waste products at a certain rate during de novo synthesis, or are caused by cellular stress, or due to disease-causing mutations (Aridor and Hannan <xref ref-type="bibr" rid="CR5">2002</xref>; Gregersen et al. <xref ref-type="bibr" rid="CR41">2006</xref>; Kim and Arvan <xref ref-type="bibr" rid="CR69">1998</xref>; Kopito <xref ref-type="bibr" rid="CR74">2000</xref>; Lukacs et al. <xref ref-type="bibr" rid="CR90">1994</xref>; Pet&#xE4;j&#xE4;-Repo et al. <xref ref-type="bibr" rid="CR124">2000</xref>; Schubert et al. <xref ref-type="bibr" rid="CR139">2000</xref>; Turner and Varshavsky <xref ref-type="bibr" rid="CR160">2000</xref>; Ward and Kopito <xref ref-type="bibr" rid="CR167">1994</xref>). Once recognized as non-native or incompletely assembled, those proteins will be removed and degraded by a process generally termed ERAD, for ER-associated degradation (Hirsch et al. <xref ref-type="bibr" rid="CR49">2004</xref>; Meusser et al. <xref ref-type="bibr" rid="CR100">2005</xref>).</p>
      <p>For secretory and membrane proteins, the molecular machinery involved in the recognition, retention and dislocation of aberrant proteins has been identified to a certain detail (Carvalho et al. <xref ref-type="bibr" rid="CR21">2006</xref>; Denic et al. <xref ref-type="bibr" rid="CR26">2006</xref>; Hirsch et al. <xref ref-type="bibr" rid="CR48">2003</xref>; Ismail and Ng <xref ref-type="bibr" rid="CR56">2006</xref>; Katiyar et al. <xref ref-type="bibr" rid="CR67">2005</xref>; Li et al. <xref ref-type="bibr" rid="CR78">2006</xref>; Lilley and Ploegh <xref ref-type="bibr" rid="CR79">2004</xref>; Schuberth and Buchberger <xref ref-type="bibr" rid="CR138">2005</xref>; Tsai et al. <xref ref-type="bibr" rid="CR159">2002</xref>; Ye et al. <xref ref-type="bibr" rid="CR177">2003</xref>, <xref ref-type="bibr" rid="CR178">2004</xref>). The ensuing final step consists of polyubiquitination of aberrant proteins condemning them for degradation by proteasomes (Eisele et al. <xref ref-type="bibr" rid="CR31">2006</xref>; Hochstrasser <xref ref-type="bibr" rid="CR50">1996</xref>; Jarosch et al. <xref ref-type="bibr" rid="CR61">2002</xref>; McCracken and Brodsky <xref ref-type="bibr" rid="CR93">2005</xref>; Wolf and Hilt <xref ref-type="bibr" rid="CR171">2004</xref>; Zwickl et al. <xref ref-type="bibr" rid="CR186">2002</xref>). In addition to various chaperones aiding proteins to achieve their proper conformation, various machinery proteins are involved in the recognition and retention of aberrant proteins. For glycoproteins, the importance of specific oligosaccharidic structures generated initially by trimming glucosidase II and UDP-glucose:glycoprotein glucosyltransferase and later on by ER-mannosidase I has been recognized (Helenius and Aebi <xref ref-type="bibr" rid="CR45">2004</xref>; Parodi <xref ref-type="bibr" rid="CR117">2000</xref>; Roth <xref ref-type="bibr" rid="CR130">2002</xref>; Roth et al. <xref ref-type="bibr" rid="CR131">2002</xref>). Glycoproteins bearing monoglucosylated oligosaccharides will be bound by calnexin or calreticulin. If the aberrant glycoproteins are considered, binding to calnexin or calreticulin will protect them temporarily from degradation. The complete deglucosylation by glucosidase II will result in their exit from the calnexin/calreticulin cycle. Subsequent trimming of mannose residue(s) of the oligosaccharide B branch by ER-mannosidase I opens the gate to dislocation and degradation of aberrant proteins. The link between the calnexin/calreticulin cycle and the dislocation process is apparently provided by two lectin-like proteins: EDEM1 (yeast ortholog Htm1p/Mnl1p) (Hosokawa et al. <xref ref-type="bibr" rid="CR51">2001</xref>; Jakob et al. <xref ref-type="bibr" rid="CR60">2001</xref>; Kanehara et al. <xref ref-type="bibr" rid="CR66">2007</xref>; Nakatsukasa et al. <xref ref-type="bibr" rid="CR105">2001</xref>; Oda et al. <xref ref-type="bibr" rid="CR107">2003</xref>) and Yos9p (mammalian orthologues OS-9 and XTP3-B) (Bhamidipati et al. <xref ref-type="bibr" rid="CR11">2005</xref>; Buschhorn et al. <xref ref-type="bibr" rid="CR17">2004</xref>; Gauss et al. <xref ref-type="bibr" rid="CR37">2006</xref>; Kanehara et al. <xref ref-type="bibr" rid="CR66">2007</xref>; Kostova and Wolf <xref ref-type="bibr" rid="CR76">2005</xref>; Szathmary et al. <xref ref-type="bibr" rid="CR150">2005</xref>).</p>
      <p>Depending on the type of protein and the location of the lesion, different ERAD dislocation pathways have been identified (Carvalho et al. <xref ref-type="bibr" rid="CR21">2006</xref>; Denic et al. <xref ref-type="bibr" rid="CR26">2006</xref>; Ismail and Ng <xref ref-type="bibr" rid="CR56">2006</xref>; Schuberth and Buchberger <xref ref-type="bibr" rid="CR138">2005</xref>). Aberrant luminal proteins and membrane proteins with a defect in their luminal domain undergo the ERAD-L pathway, which is defined by the E3 ubiquitin ligase Hrd1p complex. The Hrd1p complex consists of several proteins including Hrd3p, an E2 complex (Ubc7p and its membrane-anchoring factor Cue1p), the Cdc48p complex (AAA-ATPase Cdc48p or p97, the Ufd1 and Npl4 cofactors, and the Ubx2p membrane anchor), Der1p, Yos9p, Kar2p (BiP) and Usa1p. It should be noted that the actual function of some of those proteins in the complex remains to be established. Aberrant membrane proteins with lesions in their cytosolic domain enter the ERAD-C pathway organized by the E3 ubiquitin ligase Doa10p complex. This complex is comparably simple and consists in addition to Doa10p only of the E2 complex and the Cdc48p complex. The ERAD-M pathway is followed by membrane proteins with a lesion in their transmembrane domain and involves only Hrd1p and Hrd3p. These dislocation pathways were established for yeast cells but most probably will apply to higher eukaryotes as well because of the evolutionary conservation of the ERAD pathways. The Doa10p complex also operates in the polyubiquitination of aberrant cytosolic and nuclear proteins, in addition to the ERAD-C pathway (Neuber et al. <xref ref-type="bibr" rid="CR106">2005</xref>; Ravid et al. <xref ref-type="bibr" rid="CR128">2006</xref>; Swanson et al. <xref ref-type="bibr" rid="CR149">2001</xref>).</p>
      <p>This review will focus on how immunocytochemical labeling and electron microscopic analysis have helped to disclose the in situ subcellular distribution pattern of some of the key machinery proteins of the protein quality control, the organelle changes due to the presence of misfolded proteins, and the efficiency of synthetic chaperones to rescue disease-causing trafficking defects of aberrant proteins.</p>
    </sec>
    <sec id="Sec2">
      <title>Machinery proteins of the protein quality control reside beyond the ER</title>
      <p>For the quality control of glycoprotein folding, glucosidase II (Gls II) and UDP-glucose:glycoprotein glucosyltransferase (GT) in connection with the calnexin/calreticulin cycle are of eminent importance (Helenius and Aebi <xref ref-type="bibr" rid="CR45">2004</xref>; Parodi <xref ref-type="bibr" rid="CR117">2000</xref>; Roth <xref ref-type="bibr" rid="CR130">2002</xref>). Gls II is a luminal glycoprotein, which exists in two isoforms (Pelletier et al. <xref ref-type="bibr" rid="CR122">2000</xref>; Ziak et al. <xref ref-type="bibr" rid="CR181">2001</xref>) and does not contain known ER retention signals of the C-terminal KDEL type, nor any hydrophobic region characteristic of transmembrane proteins (Flura et al. <xref ref-type="bibr" rid="CR35">1997</xref>; Trombetta et al. <xref ref-type="bibr" rid="CR158">1996</xref>). As depicted in Fig. <xref rid="Fig1" ref-type="fig">1</xref>a, Gls II acts second to glucosidase I by removing the two inner &#x3B1;1,3-linked glucose residues (Brada and Dubach <xref ref-type="bibr" rid="CR13">1984</xref>; Burns and Touster <xref ref-type="bibr" rid="CR15">1982</xref>). The presence of three or two glucose residues on oligosaccharides can be considered to represent a trimming glyco-code whereas one glucose residue represents a trimming as well as folding glyco-code (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b) (Jakob et al. <xref ref-type="bibr" rid="CR59">1998b</xref>). The involvement of Gls II and of mono-glucosylated oligosaccharides generated by the enzyme in the protein quality control is well documented (Hammond et al. <xref ref-type="bibr" rid="CR43">1994</xref>; Hebert et al. <xref ref-type="bibr" rid="CR44">1995</xref>; Jakob et al. <xref ref-type="bibr" rid="CR58">1998a</xref>, <xref ref-type="bibr" rid="CR59">b</xref>). By confocal immunofluorescence, Gls II not unexpectedly exhibited a pattern typically observed for the ER as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>b (Roth et al. <xref ref-type="bibr" rid="CR132">2003</xref>; Zuber et al. <xref ref-type="bibr" rid="CR183">2001</xref>). By high-resolution immunoelectron microscopy, ER localization of Gls II could be definitely established (Lucocq et al. <xref ref-type="bibr" rid="CR89">1986</xref>; Zuber et al. <xref ref-type="bibr" rid="CR182">2000</xref>, <xref ref-type="bibr" rid="CR183">2001</xref>). In addition to the rough ER including the nuclear envelope and the transitional ER, the smooth ER was also positive for Gls II. However, with the superior resolution of electron microscopic immunogold labeling, Gls II was additionally found in tubulovesicular clusters between transitional ER and the cis Golgi apparatus. They represent pre-Golgi intermediates involved in antero- and retrograde transport of cargo (Appenzeller-Herzog and Hauri <xref ref-type="bibr" rid="CR3">2006</xref>; Bannykh and Balch <xref ref-type="bibr" rid="CR7">1997</xref>, <xref ref-type="bibr" rid="CR8">1998</xref>; Hammond and Glick <xref ref-type="bibr" rid="CR42">2000</xref>; Palade <xref ref-type="bibr" rid="CR114">1975</xref>; Saraste et al. <xref ref-type="bibr" rid="CR135">1987</xref>; Schweizer et al. <xref ref-type="bibr" rid="CR140">1988</xref>).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Schematic presentation of the oligosaccharide trimming pathway by glucosidase I (<italic>Gls I</italic>), glucosidase II (<italic>Gls II</italic>), UDP-glucose:glycoprotein glucosyltransferase (GT) and ER-mannosidase I (ER-Man I)</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig1_HTML" id="MO17"/></fig><fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Double confocal immunofluorescence for UDP-glucose:glycoprotein glucosyltransferase (<bold>a</bold>) and glucosidase II (<bold>b</bold>) demonstrates co-distribution (<bold>c</bold>) of the two protein quality control machinery proteins in cultured clone 9 hepatocytes. Immunogold localization of UDP-glucose:glycoprotein glucosyltransferase in an ultrathin frozen section of clone 9 hepatocytes reveals immunoreactivity in the rough ER (<italic>ER</italic>) including nuclear envelope and a pre-Golgi intermediate (<italic>pGI</italic>). The cisternal stack of the Golgi apparatus (<italic>GA</italic>) is not labeled</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig2_HTML" id="MO18"/></fig></p>
      <p>Mono-glucosylated oligosaccharides of glycoproteins are targeted by the calnexin/calreticulin cycle and after being deglucosylated by Gls II, will be targeted by GT if not correctly folded (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). GT apparently senses exposed patches of charged amino acids and reglucosylates the aberrant glycoproteins, which is followed by their re-entry in the calnexin/calreticulin cycle (Parodi et al. <xref ref-type="bibr" rid="CR118">1983</xref>; Sousa and Parodi <xref ref-type="bibr" rid="CR147">1995</xref>; Trombetta and Parodi <xref ref-type="bibr" rid="CR157">2003</xref>). When the subcellular distribution of GT was studied by confocal immunofluorescence, its labeling pattern (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a) was alike that observed for Gls II (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>b; Zuber et al. <xref ref-type="bibr" rid="CR183">2001</xref>). By immunoelectron microscopy, GT was detectable in the rough ER including the nuclear envelope and the transitional ER as well as the smooth ER (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>d). Unlike Gls II, for which the labeling intensity over rough and smooth ER was equal, labeling intensity for GT over smooth ER was only 11% that of the rough ER. GT immunolabeling was also discovered in the pre-Golgi intermediates (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>d). Notably, the pre-Golgi intermediate immunolabeling for GT was approximately twice that of rough ER (Zuber et al. <xref ref-type="bibr" rid="CR183">2001</xref>). Double immunogold labeling for GT combined with the pre-Golgi intermediate marker ERGIC-53 and the COPII component sec23p (Hughes and Stephens <xref ref-type="bibr" rid="CR55">2008</xref>) proved the identity of the GT-labeled structures. Interestingly, specific immunogold labeling for calreticulin was also observed in the pre-Golgi intermediates (Zuber et al. <xref ref-type="bibr" rid="CR182">2000</xref>, <xref ref-type="bibr" rid="CR183">2001</xref>).</p>
      <p>Together, these results provided new insight into the in situ subcellular organization of some key elements of the protein quality control machinery. Gls II, GT and calreticulin were not only present in the rough ER, as expected, but also in the smooth ER and unequivocally present in pre-Golgi intermediates. This pattern was found in different rat cell lines and tissues as well as <italic>Drosophila</italic> tissue and cell lines. The presence of three functionally closely associated proteins is a strong evidence for the involvement of pre-Golgi intermediates in protein quality control. Of course, immunolocalization provides no direct evidence for the functionality of the detected protein at a certain location. However, there is no reason to assume that Gls II, GT and calreticulin would be only functional in the ER. Studies in yeast have provided strong evidence that multiple, sequentially acting quality control checkpoints exist along the secretory pathway extending as far as to the Golgi apparatus (Arvan et al. <xref ref-type="bibr" rid="CR6">2002</xref>; Caldwell et al. <xref ref-type="bibr" rid="CR19">2001</xref>; Sayeed and Ng <xref ref-type="bibr" rid="CR137">2005</xref>; Taxis et al. <xref ref-type="bibr" rid="CR154">2002</xref>; Vashist et al. <xref ref-type="bibr" rid="CR164">2001</xref>; Vashist and Ng <xref ref-type="bibr" rid="CR163">2004</xref>; Younger and Chen <xref ref-type="bibr" rid="CR179">2006</xref>). In mammalian and insect cells, protein quality control is apparently not restricted to the ER, and the pre-Golgi intermediates appear to be involved in this fundamental cellular process as well. As will be discussed later, pre-Golgi intermediates represent not only a quality control checkpoint, but are also sites of accumulation of aberrant proteins.</p>
    </sec>
    <sec id="Sec3">
      <title>The ERAD factor EDEM1 defines a novel vesicular ER exit pathway</title>
      <p>As mentioned in the &#x201C;<xref rid="Sec1" ref-type="sec">Introduction</xref>&#x201D;, an impressive body of molecular and functional data exists concerning the macromolecular assemblies involved in the various ERAD pathways. The current well-founded basic conception of ERAD in yeast and higher eukaryotes is that the aberrant proteins after being removed from folding cycles are dislocated to the cytosol and eventually degraded by the 26S proteasome, and that this occurs in the ER. It is not clear whether this is a randomly occurring event or a more structured affair. Recent studies on EDEM1 in mammalian cells have provided preliminary evidence for a high level of subcellular organization.</p>
      <p>The discovery that the Man<sub>8</sub> B isomer oligosaccharide was actively involved in ERAD-L (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c) in yeast (Jakob et al. <xref ref-type="bibr" rid="CR58">1998a</xref>) and mammalian cells (Liu et al. <xref ref-type="bibr" rid="CR82">1999</xref>) paved the way to the identification of a lectin-like protein with sequence similarity to class I &#x3B1;1,2-mannosidases in yeast -Htm1p/Mnl1p- and mammalian cells -EDEM1- (Hosokawa et al. <xref ref-type="bibr" rid="CR51">2001</xref>; Jakob et al. <xref ref-type="bibr" rid="CR60">2001</xref>; Nakatsukasa et al. <xref ref-type="bibr" rid="CR105">2001</xref>). EDEM1 of mammalian cells is a soluble glycoprotein (Olivari et al. <xref ref-type="bibr" rid="CR110">2005</xref>; Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>), which is regulated by the unfolded protein response (Hosokawa et al. <xref ref-type="bibr" rid="CR51">2001</xref>) and seems to connect the calnexin/calreticulin cycle to the dislocation process (Molinari et al. <xref ref-type="bibr" rid="CR101">2003</xref>; Oda et al. <xref ref-type="bibr" rid="CR107">2003</xref>). EDEM1 appears to exist in complex with the dislocation proteins Derlin-2 and -3, and the AAA ATPase p97 (Oda et al. <xref ref-type="bibr" rid="CR108">2006</xref>). It is not fully understood how EDEM1 interacts with aberrant proteins. However, there is evidence for interaction with ER-mannosidase I-trimmed oligosaccharides such as depicted in Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (Hosokawa et al. <xref ref-type="bibr" rid="CR52">2003</xref>). Overexpression of EDEM1 has been shown to prevent formation of dimers of misfolded Null Hong Kong variant of alpha1-antitrypsin (Hosokawa et al. <xref ref-type="bibr" rid="CR53">2006</xref>). Notably, EDEM1 and ER-mannosidase I do not exist in complexes, which can be immunoprecipitated (Hosokawa et al. <xref ref-type="bibr" rid="CR52">2003</xref>).</p>
      <p>Recently, the subcellular distribution of endogenous EDEM1 in various mammalian cell types was established with a specific anti-peptide antibody (Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>). Unexpectedly, its immunofluorescence pattern did not correlate with that of calnexin and other ER marker proteins. Rather, an unusual pattern of well distributed punctate structures along with some localized finger-like structures was revealed (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a&#x2013;c). The distribution patterns of endogenous EDEM1 and that of overexpressed tagged EDEM1 were dramatically different: instead of a punctate, non-ER pattern, a typical reticular ER pattern plus punctate staining was observed (Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>). This striking difference in subcellular distribution between endogenous EDEM1 and overexpressed tagged EDEM1 was confirmed by Optiprep density gradients. Endogenous EDEM1 was restricted to the densest fractions, whereas tagged EDEM1 showed the same broad distribution as observed for calnexin, sec61&#x3B2;, and Derlin-1 and -2 (Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>). In this context, it needs to be emphasized that previous biochemical analyses of EDEM1 interaction with quality control machinery proteins and ERAD substrates were performed with cells transiently overexpressing tagged EDEM1 (Hosokawa et al. <xref ref-type="bibr" rid="CR52">2003</xref>; Molinari et al. <xref ref-type="bibr" rid="CR101">2003</xref>; Oda et al. <xref ref-type="bibr" rid="CR107">2003</xref>). The nature of the EDEM1 immunofluorescence pattern was clarified by immunogold labeling and serial section analysis (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>d&#x2013;h). It revealed the presence of EDEM1-reactive buds along rough ER cisternae which apparently gave raise to &#x223C;150&#xA0;nm vesicles. These buds and vesicles were devoid of a COPII coat, formed outside the canonical ER exit sites of the transitional ER and were not found in the tubulovesicular clusters of pre-Golgi intermediates (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>i). Occasionally, EDEM1 luminal immunolabeling in limited parts of distended ER cisternae was observed, which accounted for approximately 11% of the immunogold labeling for GT. Double confocal immunofluorescence for endogenous EDEM1 in rat hepatoma clone 9 cells stably expressing the Null Hong Kong variant alpha 1-antitrypsin showed co-distribution of the two proteins (Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>). Together, these data revealed the existence of a vesicular transport pathway out of the rough ER through which the ERAD factor EDEM1 and an ERAD substrate became sequestered from the early secretory pathway. Through this pathway potentially harmful aberrant luminal proteins can be removed. These findings also indicate that the Gls II and GT containing pre-Golgi intermediates appear to be not involved in the dislocation of an ERAD-L substrate.
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Double confocal immunofluorescence for endogenous EDEM1 (<bold>a</bold>) and calnexin (<bold>b</bold>) reveals different distribution patterns for the two proteins (<bold>c</bold>) in human HepG2 cells. Detection of endogenous EDEM1 by immunogold labeling of ultrathin frozen sections (<bold>e</bold>) or pre-embedding immunoperoxidase labeling (<bold>d</bold>, <bold>f</bold>&#x2013;<bold>h</bold>) reveals sparse labeling in the lumen of ER cisternae (<italic>arrowheads</italic> in <bold>e</bold> and <bold>f</bold>) and intense labeling over ER buds and vesicles pinching-off the ER (from Zuber et al. <xref ref-type="bibr" rid="CR185">2007</xref>). The subcellular distribution pattern of endogenous EDEM1 is schematically depicted in (<bold>i</bold>). In contrast to COPII-coated buds, which are formed at the transitional ER (TE) and give raise to COPII-coated vesicles present in pre-Goli intermediates (pre GI), EDEM1-positive buds occur outside the transitional ER and EDEM1-positive COPII-unreactive vesicles form clusters in the cytoplasm</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig3_HTML" id="MO19"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Endomannosidase assigns glucose trimming function to the Golgi apparatus</title>
      <p>It is generally assumed the glucose trimming occurs exclusively by Gls I and II and, therefore, is limited to the ER and pre-Golgi intermediates. However, under conditions of inhibition of trimming glucosidases, formation of mature oligosaccharides has been observed. This apparent paradox could be explained by the existence of an alternate glucose-trimming pathway by neutral endo-alpha-mannosidase (Lubas and Spiro <xref ref-type="bibr" rid="CR87">1987</xref>, <xref ref-type="bibr" rid="CR88">1988</xref>; Moore and Spiro <xref ref-type="bibr" rid="CR102">1990</xref>, <xref ref-type="bibr" rid="CR103">1992</xref>; Spiro <xref ref-type="bibr" rid="CR148">2000</xref>). Endomannosidase is currently the only known endoglycosidase. In contrast to the trimming Gls I and II, it cleaves internally between the glucose-substituted mannose and the remaining oligosaccharide (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). Its substrate specificity (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a) is basically that of Gls I and II (Moore and Spiro <xref ref-type="bibr" rid="CR102">1990</xref>, <xref ref-type="bibr" rid="CR103">1992</xref>; Rabouille and Spiro <xref ref-type="bibr" rid="CR126">1992</xref>). However, unlike Gls I and II, ER-mannosidase I trimmed mono-glucosylated oligosaccharides are a substrate of endomannosidase. The resulting Man<sub>8&#x2013;5 </sub>GlcNAc isomer A is the specific product of endomannosidase. It should be noted that this oligosaccharide is no more a substrate for reglucosylation by GT. Biochemically, activity for endomannosidase was found to be enriched in Golgi membranes (Lubas and Spiro <xref ref-type="bibr" rid="CR87">1987</xref>). By immunofluorescence (Dong et al. <xref ref-type="bibr" rid="CR29">2000</xref>; Zuber et al. <xref ref-type="bibr" rid="CR182">2000</xref>), endomannosidase exhibited a crescent-shaped perinuclear staining and fine punctate staining throughout the cytoplasm which partially overlapped with immunofluorescence for Gls Golgi mannosidase II (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b&#x2013;d). High-resolution immunoelectron microscopy demonstrated endomannosidase in the peripheral and Golgi-associated pre-Golgi intermediates as well as cis and medial cisternae of the Golgi apparatus (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>e) (Zuber et al. <xref ref-type="bibr" rid="CR182">2000</xref>). Trans cisternae of the Golgi apparatus and the trans Golgi network were unreactive. Quantification revealed &#x223C;85% of the immunogold labeling for endomannosidase in the Golgi apparatus and &#x223C;15% in pre-Golgi intermediates. Although, both endomannosidase and Gls II could be detected in pre-Golgi intermediates by double immunogold labeling, they labeled different elements of the vesiculotubular clusters (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>e). Thus, endomannosidase and Gls I and II exhibited non-overlapping subcellular distributions (Roth et al. <xref ref-type="bibr" rid="CR132">2003</xref>; Zuber et al. <xref ref-type="bibr" rid="CR182">2000</xref>). Functionally, the presence of endomannosidase in the ER would interfere with the action of glucosyltransferase by preventing the reglucosylation of misfolded glycoproteins. Together, these findings demonstrating a predominantly Golgi apparatus localization of endomannosidase strongly indicated that glucose trimming of N-linked oligosaccharides is not limited to the ER.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>The various oligosaccharidic substrates of endomannosidase are depicted in (<bold>a</bold>). Like trimming glucosidases, endomannosidase trimms Gls<sub>1&#x2013;3</sub>Man<sub>9</sub>GlcNAc<sub>2</sub>, and unlike trimming glucosidase II, monoglucosylated oligosaccharides with mannose-trimmed B and C branches. Double confocal immunofluorescence for endomannosidase (<bold>b</bold>) and Golgi mannosidase II (<bold>c</bold>) reveals co-distribution of the two enzymes (<bold>d</bold>) in clone 9 hepatocytes. Double immunogold labeling for endomannosidase (small gold particles, <italic>arrowheads</italic>) and glucosidase II (large gold particles, <italic>arrows</italic>) reveals endomannosidase localization in cis and middle Golgi apparatus cisternae (<bold>g</bold>), whereas glucosidase II is observd in rough ER including nuclear envelope. Non-overlapping immunogold labeling for both enzymes exists in pre-Golgi intermediates. <italic>N</italic>: nucleus, <italic>PM</italic>: plasma membrane. Micrographs <bold>b</bold>&#x2013;<bold>e</bold> are from Zuber et al. (<xref ref-type="bibr" rid="CR182">2000</xref>)</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig4_HTML" id="MO20"/></fig></p>
      <p>Since glucose trimming is indispensable for the synthesis of mature oligosaccharide side chains, deglucosylation by endomannosidase in the Golgi apparatus ensures that this important process is not blocked. Further biochemical and morphological analyses demonstrated that Golgi apparatus localized endomannosidase-processed oligosaccharides of alpha 1-antitrypsin irrespective of their folding state (Torossi et al. <xref ref-type="bibr" rid="CR156">2006</xref>). From the literature, it is well known that disease-causing misfolded glycoproteins to a certain extent might escape the protein quality control and become secreted (Cox <xref ref-type="bibr" rid="CR25">2001</xref>; Desnick et al. <xref ref-type="bibr" rid="CR27">2001</xref>). As a case in point, in humans suffering from alpha1-antitrypsin deficiency, the Z-variant of alpha1-antitrypsin not only becomes partially secreted, but also is active as serine protease inhibitor (Cabral et al. <xref ref-type="bibr" rid="CR18">2002</xref>; Teckman and Perlmutter <xref ref-type="bibr" rid="CR155">1996</xref>). As experimentally shown for the Z-variant of alpha1-antitrypsin (Torossi et al. <xref ref-type="bibr" rid="CR156">2006</xref>), endomannosidase provided a back-up mechanism for its de-glucosylation en route through the Golgi apparatus. Processing of its oligosaccharides to mature ones is apparently important for their proper trafficking and correct functioning.</p>
    </sec>
    <sec id="Sec5">
      <title>Organelle changes due to intracellular accumulation of misfolded proteins</title>
      <p>As a general rule, misfolded proteins become targeted by the protein quality control and following polyubiquitination will be degraded by proteasomes (Eisele et al. <xref ref-type="bibr" rid="CR31">2006</xref>; Hochstrasser <xref ref-type="bibr" rid="CR50">1996</xref>; Jarosch et al. <xref ref-type="bibr" rid="CR61">2002</xref>; McCracken and Brodsky <xref ref-type="bibr" rid="CR93">2005</xref>; Wolf and Hilt <xref ref-type="bibr" rid="CR171">2004</xref>; Zwickl et al. <xref ref-type="bibr" rid="CR186">2002</xref>). Depending on various factors such as the efficiency of the ubiquitin&#x2013;proteasome system, the intracellular amounts of misfolded glycoproteins and their biophysical properties as well as interactions with other proteins, a whole spectrum of organelle changes can be observed in protein folding diseases.</p>
      <p>For some protein folding diseases, no significant structural aberrations of the early secretory pathways could be observed. An example is Fabry&#x2019;s disease, an inherited deficiency of lysosomal alpha-galactosidase A (alpha-Gal A), which causes progressive lysosomal glycosphingolipid accumulation (mainly globotriosylceramide Gb3) (Desnick et al. <xref ref-type="bibr" rid="CR27">2001</xref>). Disease-causing mutant alpha-Gal A could be shown by immunofluorescence to be retained in the ER where it existed in complexes with the chaperone BiP (Yam et al. <xref ref-type="bibr" rid="CR172">2005</xref>, <xref ref-type="bibr" rid="CR173">2006</xref>). From this, we concluded that recognition and ER-retention of the mutant alpha-Gal A by the protein quality control machinery constituted the mechanism leading to lysosomal deficiency in alpha-Gal A. Electron microscopic analysis of cultured fibroblast from Fabry patients harboring different mutations did not reveal significant changes of the morphology of the ER and the pre-Golgi intermediates. As expected, the fibroblasts contained numerous large lysosomes with characteristic multilamellar inclusions. Thus, the intracellularly retained mutant alpha-Gal A apparently became dislocated and was efficiently degraded by the ubiquitin&#x2013;proteasome system. A similar situation was observed for a polytope membrane protein, aquaporin-2, whose folding mutants can cause renal diabetes insipidus (Canfield et al. <xref ref-type="bibr" rid="CR20">1997</xref>; Morello and Bichet <xref ref-type="bibr" rid="CR104">2001</xref>). The T126M mutant aquaporin-2 was found to be retained in the ER and efficiently degraded by proteasomes without causing ER dilatation (Hirano et al. <xref ref-type="bibr" rid="CR47">2003</xref>). ER retention and rapid proteasomal degradation are also hallmarks of the pulmonary form of alpha 1-antitrypsin deficiency (Lomas and Parfrey <xref ref-type="bibr" rid="CR84">2004</xref>; Sifers et al. <xref ref-type="bibr" rid="CR143">1988</xref>). However, other types of protein folding diseases have been shown to result in the distention of the ER cisternae. One example is the congenital hypothyroid goiter in which the mutant thyroglobulin is misfolded (Kim et al. <xref ref-type="bibr" rid="CR70">1996</xref>; Kim and Arvan <xref ref-type="bibr" rid="CR69">1998</xref>; Kim et al. <xref ref-type="bibr" rid="CR71">1998</xref>, <xref ref-type="bibr" rid="CR72">2000</xref>; Medeiros Neto et al. <xref ref-type="bibr" rid="CR99">1996</xref>). In disorders of procollagen biosynthesis, distended ER cisternae were also observed (Bogaert et al. <xref ref-type="bibr" rid="CR12">1992</xref>). Other examples are represented by LDL receptor class 2 mutants (Lehrman et al. <xref ref-type="bibr" rid="CR77">1987</xref>; Pathak et al. <xref ref-type="bibr" rid="CR119">1988</xref>).</p>
      <p>There are protein folding diseases associated with both distended ER cisternae and enlarged pre-Golgi intermediates. A misssense mutation of the insulin 2 gene (<italic>Cys96Tyr</italic>) in Akita mice disrupting one of the two interchain disulfide bonds is associated with intracellular accumulation of misfolded proinsulin (Wang et al. <xref ref-type="bibr" rid="CR166">1999</xref>). This resulted in a significant increase of the volume density of dilated ER profiles and of the pre-Golgi intermediates (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a, b) (Fan et al. <xref ref-type="bibr" rid="CR34">2007</xref>; Zuber et al. <xref ref-type="bibr" rid="CR184">2004</xref>). For the latter, a significant increase of the tubular elements was observed. Although the mutant proinsulin was degraded through proteasomes (Wang et al. <xref ref-type="bibr" rid="CR166">1999</xref>), its accumulation in the early secretory pathway caused an activation of the unfolded protein response and induced apoptosis (Oyadomari et al. <xref ref-type="bibr" rid="CR111">2002a</xref>; Oyadomari et al. <xref ref-type="bibr" rid="CR112">2002b</xref>). Other mutant proteins such as the cystic fibrosis (Kopito <xref ref-type="bibr" rid="CR73">1999</xref>; Riordan <xref ref-type="bibr" rid="CR129">1999</xref>) causing delta F508 variant of the chloride channel (Gilbert et al. <xref ref-type="bibr" rid="CR39">1998</xref>) and misfolded major histocompatibility complex class I protein (Hsu et al. <xref ref-type="bibr" rid="CR54">1991</xref>; Raposo et al. <xref ref-type="bibr" rid="CR127">1995</xref>), have been shown to accumulate in the expanded pre-Golgi intermediates.
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Details of an insulin-producing pancreatic beta cell from Akita mice. The presence of misfolded proinsulin results in the local distention of rough ER cisternae (<italic>RER*</italic>). <italic>Arrows</italic> point to regions of transition of non-distended ER (<italic>RER</italic>) to distended ER (<italic>RER*</italic>). In addition, the pre-Golgi intermediates (<italic>pGI</italic>) are greatly enlarged. G: Golgi apparatus, TE: transitional ER. In (B), the organelle changes in terms of differences of their volume density (Vv) and differences in proinsulin distribution pattern (LI) are schematically shown (from (Zuber et al. (<xref ref-type="bibr" rid="CR184">2004</xref>)</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig5_HTML" id="MO21"/></fig></p>
      <p>Certain other misfolded proteins are accompanied by the formation of insoluble aggregates in the lumen of the ER, which physically precludes dislocation to the cytosol and exposure to proteasomes. The stress-induced so-called intracisternal granules in the pancreas of starved guinea pigs (Palade <xref ref-type="bibr" rid="CR113">1956</xref>), which are composed of aggregated proenzymes (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>a) (Geuze and Slot <xref ref-type="bibr" rid="CR38">1980</xref>; Pavelka and Roth <xref ref-type="bibr" rid="CR120">2005</xref>), form a classical example. For the liver-disease-causing alpha 1-antitrypsin Z variant, about 15% of the non-secreted mutant protein is polymerogenic and thus forms insoluble aggregates in the ER lumen, which cannot be degraded (Lomas et al. <xref ref-type="bibr" rid="CR85">1992</xref>, <xref ref-type="bibr" rid="CR86">2004</xref>) The Glu342Lys substitution of the Z-variant results in a spontaneous loop-sheet polymerization of the protein. In contrast to the above-mentioned protein folding diseases, which all have in common a loss-of-function pathogenesis, the Z-variant-caused alpha 1-antitrypsin deficiency seems to involve a pathologic gain-of-function pathogenesis (Hidvegi et al. <xref ref-type="bibr" rid="CR46">2005</xref>). The ER inclusions described above belong to the category of Russell bodies. Russell bodies represent subregions of the rough ER in which insoluble proteins accumulate (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>b) (Alanen et al. <xref ref-type="bibr" rid="CR1">1985</xref>; Kopito and Sitia <xref ref-type="bibr" rid="CR75">2000</xref>; Valetti et al. <xref ref-type="bibr" rid="CR162">1991</xref>). They are typically found in cells synthesizing mutant immunoglobulins (Alanen et al. <xref ref-type="bibr" rid="CR1">1985</xref>; Kopito and Sitia <xref ref-type="bibr" rid="CR75">2000</xref>; Mattioli et al. <xref ref-type="bibr" rid="CR78">2006</xref>; Valetti et al. <xref ref-type="bibr" rid="CR162">1991</xref>) but also in cells synthesizing, for instance, mutant myocilin. Mutations of the myocilin gene are associated with primary open-angle glaucoma (Tamm <xref ref-type="bibr" rid="CR153">2002</xref>). Mutant myocilins are secretion-incompetent and have been shown biochemically to form intracellular detergent-insoluble complexes (Gobeil et al. <xref ref-type="bibr" rid="CR40">2004</xref>; Jacobson et al. <xref ref-type="bibr" rid="CR57">2001</xref>; Sohn et al. <xref ref-type="bibr" rid="CR145">2002</xref>). In cultured cells transfected to express both mutant and wild-type myocilin, heteromeric, detergent&#x2013;insoluble protein complexes were formed which were segregated into typical Russell bodies (Yam et al. <xref ref-type="bibr" rid="CR176">2007c</xref>). Thus, myocilin-caused open-angle glaucoma represents a protein folding disease. Its pathogenesis involves a pathological gain-of-function mechanism because of the interaction and complex formation of mutant with wild-type myocilin (Gobeil et al. <xref ref-type="bibr" rid="CR40">2004</xref>; Joe et al. <xref ref-type="bibr" rid="CR62">2003</xref>; Sohn et al. <xref ref-type="bibr" rid="CR145">2002</xref>; Yam et al. <xref ref-type="bibr" rid="CR176">2007c</xref>). As a consequence, unfolded protein response factors and pro-apoptotic factors were up-regulated and cells underwent apoptosis (Yam et al. <xref ref-type="bibr" rid="CR176">2007c</xref>) as detected by the appearance of lobulated nuclei and the TUNEL assay (Taatjes et al. <xref ref-type="bibr" rid="CR151">2008</xref>).
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p><bold>a</bold> Intracisternal granules (<italic>asterisks</italic>) in the rough ER of exocrine rat pancreatic cells induced by puromycin treatment. These granules correspond to mini Russell bodies and are composed of aggregated proenzymes. <bold>b </bold>Russell bodies (<italic>RB</italic>) induced by heat shock in CHO cells. They represent distended parts of rough ER cisternae filled with protein aggregates. Note the structurally normal appearing rough ER cisternae in their neighborhood</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig6_HTML" id="MO22"/></fig></p>
      <p>All the mutant proteins discussed above are luminal or membrane proteins. What happens to aberrant cytosolic and nuclear proteins? Same like ER proteins, one extreme situation is that they become efficiently degraded by cytosolic and nuclear proteasomes subsequent to polyubiquitination (Schubert et al. <xref ref-type="bibr" rid="CR139">2000</xref>; Turner and Varshavsky <xref ref-type="bibr" rid="CR160">2000</xref>). Thus, cytosolic and nuclear quality control in normal cells suppresses the formation of aggregates of aberrant proteins by degrading them. The other extreme is represented by the formation of cytosolic and nuclear inclusion bodies due to inefficient degradation of aberrant proteins by the ubiquitin&#x2013;proteasome system. Cytosolic, non-membrane bounded inclusion bodies are generally called aggresomes (Corboy et al. <xref ref-type="bibr" rid="CR24">2005</xref>; Kopito and Sitia <xref ref-type="bibr" rid="CR75">2000</xref>). They consist of pericentriolar protein aggregates surrounded by a cage of intermediate (vimentin) filaments that are the most consistent component of aggresomes in addition to ubiquitin, proteasomes and molecular chaperones. Aggresomes can be induced experimentally by forced overexpression of aggregation-prone mutant proteins or by experimentally inhibiting proteasomes (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>) (Anton et al. <xref ref-type="bibr" rid="CR2">1999</xref>; Fan et al. <xref ref-type="bibr" rid="CR34">2007</xref>; Johnston et al. <xref ref-type="bibr" rid="CR63">1998</xref>; Wigley et al. <xref ref-type="bibr" rid="CR169">1999</xref>). On the other hand, it has been shown that protein aggregates can directly impair the function of the ubiquitin&#x2013;proteasome system (Bence et al. <xref ref-type="bibr" rid="CR9">2001</xref>). The formation of aggresomes is a multi-step process, which depends on the intact microtubules. Aggresomes are formed by the coalescence of small protein aggregates transported from the cell&#x2019;s periphery along microtubules to centrioles (Garcia-Mata et al. <xref ref-type="bibr" rid="CR36">1999</xref>; Johnston et al. <xref ref-type="bibr" rid="CR63">1998</xref>; Kawaguchi et al. <xref ref-type="bibr" rid="CR68">2003</xref>; Vidair et al. <xref ref-type="bibr" rid="CR165">1966</xref>; Wigley et al. <xref ref-type="bibr" rid="CR169">1999</xref>; Wojcik et al. <xref ref-type="bibr" rid="CR170">1996</xref>). In the nucleus, the inclusion bodies can be found in association with the promyelocytic leukemia oncogenic domains (Anton et al. <xref ref-type="bibr" rid="CR2">1999</xref>).
<fig id="Fig7"><label>Fig.&#xA0;7</label><caption><p>Formation of pericentriolar aggresomes following proteasome inhibition by lactacystin in CHO cells stably expressing misfolded proinsulin. Irregularly shaped, electron dense flocculent material is present in the cytoplasm and surrounded by intermediate filaments (<bold>a</bold>). At higher magnification, the spatial relationship between the protein aggregates and a centriole can be seen (<bold>b</bold>). Micrographs from Fan et al. (<xref ref-type="bibr" rid="CR34">2007</xref>)</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig7_HTML" id="MO23"/></fig></p>
      <p>Inclusion bodies have been observed in association with a number of chronic neurodegenerative diseases such as Parkinson&#x2019;s disease, Huntington&#x2019;s disease, Alzheimer&#x2019;s disease and amyotrophic lateral sclerosis (Johnston et al. <xref ref-type="bibr" rid="CR64">2000</xref>; Kabashi and Durham <xref ref-type="bibr" rid="CR65">2006</xref>; Rubinsztein <xref ref-type="bibr" rid="CR133">2006</xref>; Selkoe <xref ref-type="bibr" rid="CR141">2003</xref>; Shults <xref ref-type="bibr" rid="CR142">2006</xref>; Soto <xref ref-type="bibr" rid="CR146">2003</xref>). Inclusion bodies named Lewy bodies are a morphological hallmark of Parkinson&#x2019;s disease and other neurodegenerative disorders (McNaught et al. <xref ref-type="bibr" rid="CR96">2002b</xref>; Olanow et al. <xref ref-type="bibr" rid="CR109">2004</xref>; Shults <xref ref-type="bibr" rid="CR142">2006</xref>). Lewy bodies in the dopaminergic neurons resemble aggresomes and represent spherical bodies commonly composed of a core of granular material and peripheral radiating filaments. They contain a variety of proteins such as alpha-synuclein, the alpha-synuclein-binding protein synphilin-1 torsin A, neurofilaments, ubiquitin, proteasomal subunits and various heat shock proteins as well as ubiquitin-activating enzyme, ubiquitin-conjugating enzyme, ubiquitin ligase enzymes and proteasome activators. Furthermore, they contain centrosome-related gamma-tubulin and pericentrin. Thus, it has been proposed that the formation of Lewy bodies represents an aggresome-like response in dopaminergic neurons (McNaught et al. <xref ref-type="bibr" rid="CR97">2002c</xref>). Considering the observed impairment of the ubiquitin&#x2013;proteasome system in patients with Parkinson&#x2019;s disease (McNaught et al., <xref ref-type="bibr" rid="CR94">2001</xref>, <xref ref-type="bibr" rid="CR95">2002a</xref>, <xref ref-type="bibr" rid="CR98">2006</xref>), it is assumed that Lewy bodies, by segregating increasing levels of aberrant and potentially cytotoxic proteins, might protect the neurons (Olanow et al. <xref ref-type="bibr" rid="CR109">2004</xref>). It should be stressed, however, that the mechanism leading to selective neuronal death in Parkinson&#x2019;s disease is not fully understood and the role Lewy bodies might be playing needs to be studied further studies (Lindholm et al. <xref ref-type="bibr" rid="CR81">2006</xref>).</p>
    </sec>
    <sec id="Sec6">
      <title>Synthetic chaperones for treatment of protein folding disease</title>
      <p>The various protein folding diseases mentioned above can be classified based on the pathogenetic mechanism. Efficient proteasomal degradation of the misfolded protein is characteristic of the loss-of-function pathogenesis. This is the case in protein folding diseases such as cystic fibrosis, the lung form of alpha 1-antitrypsin deficiency, aquaporin 2-caused renal diabetes insipidus, Gaucher&#x2019;s disease and Fabry&#x2019;s disease. Here, the missing function of the degraded protein alone can be the cause of the clinical symptoms, or secondary effects due to substrate accumulation like in lysosomal storage diseases. Intracellular accumulation due to inefficient proteasomal degradation of misfolded proteins is representative of a pathological gain-of-function mechanism, which is combined with a loss of function. Intracellular accumulation of misfolded proteins associated or not with protein aggregation can result in the activation of the unfolded protein response leading to ER stress and apoptosis. A pathological gain-of-function mechanism can be also the cause of a dominant clinical course when the wild-type protein in complexes with the mutant protein is retained inside the cells. Examples for pathological gain-of-function pathogenesis-associated protein folding diseases are myocilin-caused open-angle glaucoma, familial hypophyseal diabetes insipidus, Parkinson&#x2019;s disease and Huntington&#x2019;s disease.</p>
      <p>Many attempts have been made to at least partially correct the protein misfolding in order to overcome their trafficking defect and to alleviate ER stress. Among other approaches, small molecule synthetic chaperones have been used in order to shift the folding equilibrium of mutant proteins towards a more native state (Arakawa et al. <xref ref-type="bibr" rid="CR4">2006</xref>; Chaudhuri and Paul <xref ref-type="bibr" rid="CR22">2006</xref>; Cohen and Kelly <xref ref-type="bibr" rid="CR23">2003</xref>; Papp and Csermely <xref ref-type="bibr" rid="CR115">2006</xref>; Perlmutter <xref ref-type="bibr" rid="CR123">2002</xref>). Chemical chaperones include osmotically active substances such as DMSO, glycerol, polyols or deuterated water, and other compounds such as 4-phenylbutyric acid (Burrows et al. <xref ref-type="bibr" rid="CR16">2000</xref>; Lim et al. <xref ref-type="bibr" rid="CR80">2004</xref>; Liu et al. <xref ref-type="bibr" rid="CR83">2004</xref>; Pedemonte et al. <xref ref-type="bibr" rid="CR121">2005</xref>; Rubenstein and Zeitlin <xref ref-type="bibr" rid="CR134">2000</xref>; Tamarappoo and Verkman <xref ref-type="bibr" rid="CR152">1998</xref>; Tveten et al. <xref ref-type="bibr" rid="CR161">2007</xref>; Welch and Brown <xref ref-type="bibr" rid="CR168">1996</xref>). Other substances such as enzyme inhibitors (Fan et al. <xref ref-type="bibr" rid="CR33">1999</xref>; Matsuda et al. <xref ref-type="bibr" rid="CR91">2003</xref>; Sawkar et al. <xref ref-type="bibr" rid="CR136">2002</xref>) and receptor ligands or antagonists {Pet&#xE4;j&#xE4;-Repo, 2002 #16211;Egan, 2002 #12283} have been shown to function as pharmacological chaperones.</p>
      <p>Here, we have chosen two examples from our work to demonstrate how immunocytochemistry and microscopy in combination with biochemical analyses can be applied to demonstrate the functionality of a chemical and a pharmacological chaperone in rescuing the consequence of disease-causing protein misfolding. It has been mentioned above that open-angle glaucoma-causing mutant myocilin forms insoluble protein aggregates in the ER lumen (Russel bodies), which result in ER stress and apoptotic cell death (Yam et al. <xref ref-type="bibr" rid="CR175">2007b</xref>). Among the other tested chemical chaperones, treatment with sodium 4-phenylbutyrate significantly reduced the amount of intracellular detergent&#x2013;insoluble myocilin aggregates and thereby the number of Russel bodies in the cells (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>a&#x2013;c), diminished mutant myocilin interaction with calreticulin and restored the secretion of mutant myocilin. As a consequence, the ER stress was released and most interesting, the apoptosis rate was reduced close to levels observed in control cells expressing wild-type myocilin (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>d). Thus, sodium 4-phenylbutyrate exerts a beneficial effect by protecting the cells from the deleterious effects of mutant myocilin. Since sodium 4-phenylbutyrate is a tissue and cell-permeable molecule, it holds the potential for topical administration in the treatment of myocilin-caused primary open-angle glaucoma.
<fig id="Fig8"><label>Fig.&#xA0;8</label><caption><p>Confocal double fluorescence of HEK 293 cells stably expressing GFP-wt and FLAG-wt myocilin reveals an ER and fine punctate pattern (<bold>a</bold>). HEK 293 cells coexpressing GFP-mutant myocilin and FLAG-wt myocilin exhibit distinct cytoplasmic aggregates, which correspond to Russell bodies (<bold>b</bold>). Treatment with the chemical chaperone sodium 4-phenylbutyrate results in reduction of the percentage of cells with myocilin-containing Russell bodies (<bold>c</bold>) and a drastic reduction of the apoptosis rate (<bold>d</bold>). <italic>Empty columns</italic> in <bold>d</bold> show values for untreated cells and filled columns for sodium 4-phenylbutyrate treated cells. From Yam et al. (<xref ref-type="bibr" rid="CR174">2007a</xref>)</p></caption><graphic position="anchor" xlink:href="418_2007_366_Fig8_HTML" id="MO24"/></fig></p>
      <p>The second example concerns Fabry&#x2019;s disease, a lysosomal storage disorder caused by a deficiency of alpha-Gal A activity in lysosomes that results in the accumulation of glycosphingolipid globotriosylceramide (Gb3). The lysosomal trafficking of mutant alpha Gal A is impaired because the enzyme is retained in the ER by the protein quality control (Yam et al. <xref ref-type="bibr" rid="CR172">2005</xref>). Others had demonstrated that the activity of mutant alpha-Gal A in vitro at neutral pH could be stabilized with the competitive enzyme inhibitor 1-deoxygalactonorijimycin (DGJ) (Fan et al. <xref ref-type="bibr" rid="CR33">1999</xref>). Treatment of cells expressing mutant alpha-Gal A with a non-inhibitory dose of DGJ enhanced the intracellular enzyme activity (Yam et al. <xref ref-type="bibr" rid="CR172">2005</xref>, <xref ref-type="bibr" rid="CR173">2006</xref>). In addition, we could demonstrate by immunofluorescence and quantitative immunogold labeling that the mutant enzyme was redistributed from the ER to lysosomes and that this trafficking was mannose 6-phosphate-dependent. The DGJ treatment resulted in release of mutant alpha-Gal A from the chaperone BiP and in its conversion in the mature lysosomal form. Double confocal immunofluorescence and immunogold labeling demonstrated that the lysosomal Gb3 storage was cleared and that the size of the lysosomes became normalized (Yam et al. <xref ref-type="bibr" rid="CR172">2005</xref>, <xref ref-type="bibr" rid="CR173">2006</xref>). Together, this demonstrated that DGJ exhibited a chaperone-like effect and induced the trafficking of ER-retained mutant alpha Gal A to lysosomes where the enzyme was catalytically active. Therefore, the pharmacological chaperone DGJ potentially offers a convenient and cost-efficient therapeutic alternative to enzyme replacement therapy.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>The work of the authors has received financial support by the Swiss National Science Foundation, the Wolfermann-N&#xE4;geli Foundation, Zurich, the Velux Foundation, Zurich, the Kamillo Eisner Foundation, Hergiswil, the Bonizzi-Theler Foundation, Zurich and the Canton of Zurich.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alanen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pira</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lassila</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Mott cells are plasma cells defective in immunoglobulin secretion</article-title>
          <source>Eur J Immunol</source>
          <year>1985</year>
          <volume>15</volume>
          <fpage>235</fpage>
          <lpage>242</lpage>
        </citation>
        <citation citation-type="display-unstructured">Alanen A, Pira U, Lassila O, Roth J, Franklin R (1985) Mott cells are plasma cells defective in immunoglobulin secretion. Eur J Immunol 15:235&#x2013;242 <pub-id pub-id-type="pmid">3979421</pub-id></citation>
      </ref>
      <ref id="CR2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anton</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schubert</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bacik</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Princiotta</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wearsch</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gibbs</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Day</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Realini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rechsteiner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bennink</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Yewdell</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Intracellular location of proteasomal degradation of a viral antigen</article-title>
          <source>J Cell Biol</source>
          <year>1999</year>
          <volume>146</volume>
          <fpage>113</fpage>
          <lpage>124</lpage>
        </citation>
        <citation citation-type="display-unstructured">Anton L, Schubert U, Bacik I, Princiotta M, Wearsch P, Gibbs J, Day P, Realini C, Rechsteiner M, Bennink J, Yewdell J (1999) Intracellular location of proteasomal degradation of a viral antigen. J Cell Biol 146:113&#x2013;124 <pub-id pub-id-type="pmid">10402464</pub-id></citation>
      </ref>
      <ref id="CR3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appenzeller-Herzog</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hauri</surname>
              <given-names>HP</given-names>
            </name>
          </person-group>
          <article-title>The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function</article-title>
          <source>J Cell Sci</source>
          <year>2006</year>
          <volume>119</volume>
          <fpage>2173</fpage>
          <lpage>2183</lpage>
        </citation>
        <citation citation-type="display-unstructured">Appenzeller-Herzog C, Hauri HP (2006) The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J Cell Sci 119:2173&#x2013;2183 <pub-id pub-id-type="pmid">16723730</pub-id></citation>
      </ref>
      <ref id="CR4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arakawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ejima</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsumoto</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Small molecule pharmacological chaperones: from thermodynamic stabilization to pharmaceutical drugs</article-title>
          <source>Biochimica Biophysic Acta Proteins Proteomics</source>
          <year>2006</year>
          <volume>1764</volume>
          <fpage>1677</fpage>
          <lpage>1687</lpage>
        </citation>
        <citation citation-type="display-unstructured">Arakawa T, Ejima D, Kita Y, Tsumoto K (2006) Small molecule pharmacological chaperones: from thermodynamic stabilization to pharmaceutical drugs. Biochimica Biophysic Acta Proteins Proteomics 1764:1677&#x2013;1687 </citation>
      </ref>
      <ref id="CR5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aridor</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hannan</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Traffic jams II: an update of diseases of intracellular transport</article-title>
          <source>Traffic</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>781</fpage>
          <lpage>790</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aridor M, Hannan LA (2002) Traffic jams II: an update of diseases of intracellular transport. Traffic 3:781&#x2013;790 <pub-id pub-id-type="pmid">12383344</pub-id></citation>
      </ref>
      <ref id="CR6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arvan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>RamosCastaneda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems</article-title>
          <source>Traffic</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>771</fpage>
          <lpage>780</lpage>
        </citation>
        <citation citation-type="display-unstructured">Arvan P, Zhao X, RamosCastaneda J, Chang A (2002) Secretory pathway quality control operating in Golgi, plasmalemmal, and endosomal systems. Traffic 3:771&#x2013;780 <pub-id pub-id-type="pmid">12383343</pub-id></citation>
      </ref>
      <ref id="CR7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bannykh</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Balch</surname>
              <given-names>WE</given-names>
            </name>
          </person-group>
          <article-title>Membrane dynamics at the endoplasmic reticulum&#x2013;Golgi interface</article-title>
          <source>J Cell Biol</source>
          <year>1997</year>
          <volume>138</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bannykh SI, Balch WE (1997) Membrane dynamics at the endoplasmic reticulum&#x2013;Golgi interface. J Cell Biol 138:1&#x2013;4 <pub-id pub-id-type="pmid">9214376</pub-id></citation>
      </ref>
      <ref id="CR8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bannykh</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Balch</surname>
              <given-names>WE</given-names>
            </name>
          </person-group>
          <article-title>Selective transport of cargo between the endoplasmic reticulum and Golgi compartments</article-title>
          <source>Histochem Cell Biol</source>
          <year>1998</year>
          <volume>109</volume>
          <fpage>463</fpage>
          <lpage>475</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bannykh SI, Balch WE (1998) Selective transport of cargo between the endoplasmic reticulum and Golgi compartments. Histochem Cell Biol 109:463&#x2013;475 <pub-id pub-id-type="pmid">9681628</pub-id></citation>
      </ref>
      <ref id="CR9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bence</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Sampat</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Impairment of the ubiquitin&#x2013;proteasome system by protein aggregation</article-title>
          <source>Science</source>
          <year>2001</year>
          <volume>292</volume>
          <fpage>1552</fpage>
          <lpage>1555</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bence NF, Sampat RM, Kopito RR (2001) Impairment of the ubiquitin&#x2013;proteasome system by protein aggregation. Science 292:1552&#x2013;1555 <pub-id pub-id-type="pmid">11375494</pub-id></citation>
      </ref>
      <ref id="CR10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bennett</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Bence</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Jayakumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Global impairment of the ubiquitin&#x2013;proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation</article-title>
          <source>Mol Cell</source>
          <year>2005</year>
          <volume>17</volume>
          <fpage>351</fpage>
          <lpage>365</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bennett EJ, Bence NF, Jayakumar R, Kopito RR (2005) Global impairment of the ubiquitin&#x2013;proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17:351&#x2013;365 <pub-id pub-id-type="pmid">15694337</pub-id></citation>
      </ref>
      <ref id="CR11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhamidipati</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Denic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Quan</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Exploration of the topological requirements of ERAD identifies Yos9p as a lectin sensor of misfolded glycoproteins in the ER lumen</article-title>
          <source>Mol Cell</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>741</fpage>
          <lpage>751</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bhamidipati A, Denic V, Quan EM, Weissman JS (2005) Exploration of the topological requirements of ERAD identifies Yos9p as a lectin sensor of misfolded glycoproteins in the ER lumen. Mol Cell 19:741&#x2013;751 <pub-id pub-id-type="pmid">16168370</pub-id></citation>
      </ref>
      <ref id="CR12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bogaert</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tiller</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Weis</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Gruber</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Rimoin</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Cohn</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Eyre</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>An amino acid substitution (Gly853&#x2192;Glu) in the collagen alpha 1(II) chain produces hypochondrogenesis</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>22522</fpage>
          <lpage>22526</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bogaert R, Tiller GE, Weis MA, Gruber HE, Rimoin DL, Cohn DH, Eyre DR (1992) An amino acid substitution (Gly853&#x2192;Glu) in the collagen alpha 1(II) chain produces hypochondrogenesis. J Biol Chem 267:22522&#x2013;22526 <pub-id pub-id-type="pmid">1429602</pub-id></citation>
      </ref>
      <ref id="CR13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brada</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dubach</surname>
              <given-names>UC</given-names>
            </name>
          </person-group>
          <article-title>Isolation of a homogeneous glucosidase II from pig kidney microsomes</article-title>
          <source>Eur J Biochem</source>
          <year>1984</year>
          <volume>141</volume>
          <fpage>149</fpage>
          <lpage>156</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brada D, Dubach UC (1984) Isolation of a homogeneous glucosidase II from pig kidney microsomes. Eur J Biochem 141:149&#x2013;156 <pub-id pub-id-type="pmid">6373255</pub-id></citation>
      </ref>
      <ref id="CR14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bukau</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Horwich</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Molecular chaperones and protein quality control</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>125</volume>
          <fpage>443</fpage>
          <lpage>451</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bukau B, Weissman J, Horwich A (2006) Molecular chaperones and protein quality control. Cell 125:443&#x2013;451 <pub-id pub-id-type="pmid">16678092</pub-id></citation>
      </ref>
      <ref id="CR15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burns</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Touster</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of glucosidase II, an endoplasmic reticulum hydrolase involved in glycoprotein biosynthesis</article-title>
          <source>J Biol Chem</source>
          <year>1982</year>
          <volume>257</volume>
          <fpage>9990</fpage>
          <lpage>10000</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burns DM, Touster O (1982) Purification and characterization of glucosidase II, an endoplasmic reticulum hydrolase involved in glycoprotein biosynthesis. J Biol Chem 257:9990&#x2013;10000 <pub-id pub-id-type="pmid">7050114</pub-id></citation>
      </ref>
      <ref id="CR16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burrows</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Willis</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Perlmutter</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>1796</fpage>
          <lpage>1801</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burrows JA, Willis LK, Perlmutter DH (2000) Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci USA 97:1796&#x2013;1801 <pub-id pub-id-type="pmid">10677536</pub-id></citation>
      </ref>
      <ref id="CR17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buschhorn</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Kostova</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Medicherla</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>A genome-wide screen identifies Yos9p as essential for ER-associated degradation of glycoproteins</article-title>
          <source>FEBS Lett</source>
          <year>2004</year>
          <volume>577</volume>
          <fpage>422</fpage>
          <lpage>426</lpage>
        </citation>
        <citation citation-type="display-unstructured">Buschhorn BA, Kostova Z, Medicherla B, Wolf DH (2004) A genome-wide screen identifies Yos9p as essential for ER-associated degradation of glycoproteins. FEBS Lett 577:422&#x2013;426 <pub-id pub-id-type="pmid">15556621</pub-id></citation>
      </ref>
      <ref id="CR18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabral</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Moremen</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Sifers</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs</article-title>
          <source>Mol Biol Cell</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>2639</fpage>
          <lpage>2650</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cabral CM, Liu Y, Moremen KW, Sifers RN (2002) Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs. Mol Biol Cell 13:2639&#x2013;2650 <pub-id pub-id-type="pmid">12181335</pub-id></citation>
      </ref>
      <ref id="CR19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caldwell</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Cooper</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>23296</fpage>
          <lpage>23303</lpage>
        </citation>
        <citation citation-type="display-unstructured">Caldwell SR, Hill KJ, Cooper AA (2001) Degradation of endoplasmic reticulum (ER) quality control substrates requires transport between the ER and Golgi. J Biol Chem 276:23296&#x2013;23303 <pub-id pub-id-type="pmid">11316816</pub-id></citation>
      </ref>
      <ref id="CR20">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Canfield</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tamarappoo</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Verkman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Holtzman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response</article-title>
          <source>Hum Mol Genet</source>
          <year>1997</year>
          <volume>6</volume>
          <fpage>1865</fpage>
          <lpage>1875</lpage>
        </citation>
        <citation citation-type="display-unstructured">Canfield M, Tamarappoo B, Moses A, Verkman A, Holtzman E (1997) Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet 6:1865&#x2013;1871 <pub-id pub-id-type="pmid">9302264</pub-id></citation>
      </ref>
      <ref id="CR21">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Goder</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rapoport</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Distinct ubiquitin&#x2013;ligase complexes define convergent pathways for the degradation of ER proteins</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>361</fpage>
          <lpage>373</lpage>
        </citation>
        <citation citation-type="display-unstructured">Carvalho P, Goder V, Rapoport TA (2006) Distinct ubiquitin&#x2013;ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126:361&#x2013;373 <pub-id pub-id-type="pmid">16873066</pub-id></citation>
      </ref>
      <ref id="CR22">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chaudhuri</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Paul</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Protein-misfolding diseases and chaperone-based therapeutic approaches</article-title>
          <source>FEBS J</source>
          <year>2006</year>
          <volume>273</volume>
          <fpage>1331</fpage>
          <lpage>1349</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chaudhuri TK, Paul S (2006) Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J 273:1331&#x2013;1349 <pub-id pub-id-type="pmid">16689923</pub-id></citation>
      </ref>
      <ref id="CR23">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic approaches to protein-misfolding diseases</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>905</fpage>
          <lpage>909</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cohen FE, Kelly JW (2003) Therapeutic approaches to protein-misfolding diseases. Nature 426:905&#x2013;909 <pub-id pub-id-type="pmid">14685252</pub-id></citation>
      </ref>
      <ref id="CR24">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corboy</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Wigley</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Aggresome formation</article-title>
          <source>Meth Mol Biol</source>
          <year>2005</year>
          <volume>301</volume>
          <fpage>305</fpage>
          <lpage>327</lpage>
        </citation>
        <citation citation-type="display-unstructured">Corboy MJ, Thomas PJ, Wigley WC (2005) Aggresome formation. Meth Mol Biol 301:305&#x2013;327 </citation>
      </ref>
      <ref id="CR25">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Cox</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Scriver</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beaudet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sly</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>&#x3B1;1-antitrypsin deficiency</article-title>
          <source>The metabolic and molecular bases of inherited disease</source>
          <year>2001</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>5559</fpage>
          <lpage>5578</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cox D (2001) &#x3B1;1-antitrypsin deficiency. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 5559&#x2013;5578 </citation>
      </ref>
      <ref id="CR26">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Quan</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Weissman</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>349</fpage>
          <lpage>359</lpage>
        </citation>
        <citation citation-type="display-unstructured">Denic V, Quan EM, Weissman JS (2006) A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation. Cell 126:349&#x2013;359 <pub-id pub-id-type="pmid">16873065</pub-id></citation>
      </ref>
      <ref id="CR27">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Desnick</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ioannou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Scriver</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beaudet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sly</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>&#x3B1;-Galactosidase a deficiency: Fabry disease</article-title>
          <source>The metabolic and molecular bases of inherited disease, vol III</source>
          <year>2001</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill</publisher-name>
          <fpage>3733</fpage>
          <lpage>3774</lpage>
        </citation>
        <citation citation-type="display-unstructured">Desnick R, Ioannou Y, Eng C (2001) &#x3B1;-Galactosidase a deficiency: Fabry disease. In: Scriver C, Beaudet A, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease, vol III. McGraw-Hill, New York, pp 3733&#x2013;3774 </citation>
      </ref>
      <ref id="CR28">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobson</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Protein folding and misfolding</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>884</fpage>
          <lpage>890</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dobson CM (2003) Protein folding and misfolding. Nature 426:884&#x2013;890 <pub-id pub-id-type="pmid">14685248</pub-id></citation>
      </ref>
      <ref id="CR29">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>ZZ</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical evaluation of endomannosidase distribution in rat tissues: evidence for cell type-specific expression</article-title>
          <source>Histochem Cell Biol</source>
          <year>2000</year>
          <volume>114</volume>
          <fpage>461</fpage>
          <lpage>467</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dong ZZ, Zuber C, Spiro MJ, Spiro RG, Roth J (2000) Immunohistochemical evaluation of endomannosidase distribution in rat tissues: evidence for cell type-specific expression. Histochem Cell Biol 114:461&#x2013;467 <pub-id pub-id-type="pmid">11201607</pub-id></citation>
      </ref>
      <ref id="CR30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Egan</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>GlocknerPagel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ambrose</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Cahill</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Pappoe</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Balamuth</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Canny</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wagner</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Geibel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Caplan</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>485</fpage>
          <lpage>492</lpage>
        </citation>
        <citation citation-type="display-unstructured">Egan ME, GlocknerPagel J, Ambrose CA, Cahill PA, Pappoe L, Balamuth N, Cho E, Canny S, Wagner CA, Geibel J, Caplan MJ (2002) Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 8:485&#x2013;492 <pub-id pub-id-type="pmid">11984593</pub-id></citation>
      </ref>
      <ref id="CR31">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisele</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Pfirrmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Mutants of the deubiquitinating enzyme Ubp14 decipher pathway diversity of ubiquitin&#x2013;proteasome linked protein degradation</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2006</year>
          <volume>350</volume>
          <fpage>329</fpage>
          <lpage>333</lpage>
        </citation>
        <citation citation-type="display-unstructured">Eisele F, Braun B, Pfirrmann T, Wolf DH (2006) Mutants of the deubiquitinating enzyme Ubp14 decipher pathway diversity of ubiquitin&#x2013;proteasome linked protein degradation. Biochem Biophys Res Commun 350:329&#x2013;333 <pub-id pub-id-type="pmid">17010312</pub-id></citation>
      </ref>
      <ref id="CR32">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ellgaard</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Helenius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Quality control in the endoplasmic reticulum</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>181</fpage>
          <lpage>191</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ellgaard L, Helenius A (2003) Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 4:181&#x2013;191 <pub-id pub-id-type="pmid">12612637</pub-id></citation>
      </ref>
      <ref id="CR33">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>JQ</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor</article-title>
          <source>Nat Med</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>112</fpage>
          <lpage>115</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fan JQ, Ishii S, Asano N, Suzuki Y (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat Med 5:112&#x2013;115 <pub-id pub-id-type="pmid">9883849</pub-id></citation>
      </ref>
      <ref id="CR34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Expression of mutant Ins2(C96Y) results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells</article-title>
          <source>Histochem Cell Biol</source>
          <year>2007</year>
          <volume>128</volume>
          <fpage>161</fpage>
          <lpage>173</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fan JY, Roth J, Zuber C (2007) Expression of mutant Ins2(C96Y) results in enhanced tubule formation causing enlargement of pre-Golgi intermediates of CHO cells. Histochem Cell Biol 128:161&#x2013;173 <pub-id pub-id-type="pmid">17647009</pub-id></citation>
      </ref>
      <ref id="CR35">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Brada</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Expression of a cDNA encoding the glucose trimming enzyme glucosidase II in CHO cells and molecular characterization of the enzyme deficiency in a mutant mouse lymphoma cell line</article-title>
          <source>Glycobiology</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>617</fpage>
          <lpage>624</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flura T, Brada D, Ziak M, Roth J (1997) Expression of a cDNA encoding the glucose trimming enzyme glucosidase II in CHO cells and molecular characterization of the enzyme deficiency in a mutant mouse lymphoma cell line. Glycobiology 7:617&#x2013;624 <pub-id pub-id-type="pmid">9254044</pub-id></citation>
      </ref>
      <ref id="CR36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Mata</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Beb&#xF6;k</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sorscher</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Sztul</surname>
              <given-names>ES</given-names>
            </name>
          </person-group>
          <article-title>Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera</article-title>
          <source>J Cell Biol</source>
          <year>1999</year>
          <volume>146</volume>
          <fpage>1239</fpage>
          <lpage>1254</lpage>
        </citation>
        <citation citation-type="display-unstructured">Garcia-Mata R, Beb&#xF6;k Z, Sorscher EJ, Sztul ES (1999) Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol 146:1239&#x2013;1254 <pub-id pub-id-type="pmid">10491388</pub-id></citation>
      </ref>
      <ref id="CR37">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gauss</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jarosch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>A complex of Yos9p and the HRD ligase integrates endoplasmic reticulum quality control into the degradation machinery</article-title>
          <source>Nat Cell Biol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>849</fpage>
          <lpage>854</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gauss R, Jarosch E, Sommer T, Hirsch C (2006) A complex of Yos9p and the HRD ligase integrates endoplasmic reticulum quality control into the degradation machinery. Nat Cell Biol 8:849&#x2013;854 <pub-id pub-id-type="pmid">16845381</pub-id></citation>
      </ref>
      <ref id="CR38">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geuze</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Slot</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Disproportional immunostaining patterns of two secretory proteins in guinea pig and rat exocrine pancreatic cells. An immunoferritin and fluorescence study</article-title>
          <source>Eur J Cell Biol</source>
          <year>1980</year>
          <volume>21</volume>
          <fpage>93</fpage>
          <lpage>100</lpage>
        </citation>
        <citation citation-type="display-unstructured">Geuze HJ, Slot JW (1980) Disproportional immunostaining patterns of two secretory proteins in guinea pig and rat exocrine pancreatic cells. An immunoferritin and fluorescence study. Eur J Cell Biol 21:93&#x2013;100 <pub-id pub-id-type="pmid">6155266</pub-id></citation>
      </ref>
      <ref id="CR39">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilbert</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Jadot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Leontieva</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wattiaux</surname>
              <given-names>D-C-S</given-names>
            </name>
            <name>
              <surname>Wattiaux</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Delta F508 CFTR localizes in the endoplasmic reticulum&#x2013;Golgi intermediate compartment in cystic fibrosis cells</article-title>
          <source>Exp Cell Res</source>
          <year>1998</year>
          <volume>242</volume>
          <fpage>144</fpage>
          <lpage>152</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gilbert A, Jadot M, Leontieva E, Wattiaux D-C-S, Wattiaux R (1998) Delta F508 CFTR localizes in the endoplasmic reticulum&#x2013;Golgi intermediate compartment in cystic fibrosis cells. Exp Cell Res 242:144&#x2013;152 <pub-id pub-id-type="pmid">9665812</pub-id></citation>
      </ref>
      <ref id="CR40">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gobeil</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rodrigue</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Moisan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Polansky</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Morissette</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2004</year>
          <volume>45</volume>
          <fpage>3560</fpage>
          <lpage>3567</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gobeil S, Rodrigue MA, Moisan S, Nguyen TD, Polansky JR, Morissette J, Raymond V (2004) Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest Ophthalmol Vis Sci 45:3560&#x2013;3567 <pub-id pub-id-type="pmid">15452063</pub-id></citation>
      </ref>
      <ref id="CR41">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gregersen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Bross</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Christensen</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Protein misfolding and human disease</article-title>
          <source>Annu Rev Gen Hum Genet</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>103</fpage>
          <lpage>124</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gregersen N, Bross P, Vang S, Christensen JH (2006) Protein misfolding and human disease. Annu Rev Gen Hum Genet 7:103&#x2013;124 </citation>
      </ref>
      <ref id="CR42">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammond</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Glick</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <article-title>Dynamics of transitional endoplasmic reticulum sites in vertebrate cells</article-title>
          <source>Mol Biol Cell</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>3013</fpage>
          <lpage>3030</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hammond AT, Glick BS (2000) Dynamics of transitional endoplasmic reticulum sites in vertebrate cells. Mol Biol Cell 11:3013&#x2013;3030 <pub-id pub-id-type="pmid">10982397</pub-id></citation>
      </ref>
      <ref id="CR43">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hammond</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Braakman</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Helenius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>913</fpage>
          <lpage>917</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hammond C, Braakman I, Helenius A (1994) Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc Natl Acad Sci USA 91:913&#x2013;917 <pub-id pub-id-type="pmid">8302866</pub-id></citation>
      </ref>
      <ref id="CR44">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hebert</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Foellmer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Helenius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum</article-title>
          <source>Cell</source>
          <year>1995</year>
          <volume>81</volume>
          <fpage>425</fpage>
          <lpage>433</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hebert DN, Foellmer B, Helenius A (1995) Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 81:425&#x2013;433 <pub-id pub-id-type="pmid">7736594</pub-id></citation>
      </ref>
      <ref id="CR45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Helenius</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aebi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Roles of N-linked glycans in the endoplasmic reticulum</article-title>
          <source>Annu Rev Biochem</source>
          <year>2004</year>
          <volume>73</volume>
          <fpage>1019</fpage>
          <lpage>1049</lpage>
        </citation>
        <citation citation-type="display-unstructured">Helenius A, Aebi M (2004) Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73:1019&#x2013;1049 <pub-id pub-id-type="pmid">15189166</pub-id></citation>
      </ref>
      <ref id="CR46">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hidvegi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>BZ</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Perlmutter</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>39002</fpage>
          <lpage>39015</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hidvegi T, Schmidt BZ, Hale P, Perlmutter DH (2005) Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem 280:39002&#x2013;39015 <pub-id pub-id-type="pmid">16183649</pub-id></citation>
      </ref>
      <ref id="CR47">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirano</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The proteasome is involved in the degradation of different aquaporin-2 mutants causing nephrogenic diabetes insipidus</article-title>
          <source>Am J Pathol</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>111</fpage>
          <lpage>120</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hirano K, Zuber C, Roth J, Ziak M (2003) The proteasome is involved in the degradation of different aquaporin-2 mutants causing nephrogenic diabetes insipidus. Am J Pathol 163:111&#x2013;120 <pub-id pub-id-type="pmid">12819016</pub-id></citation>
      </ref>
      <ref id="CR48">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Blom</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ploegh</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>A role for <italic>N</italic>-glycanase in the cytosolic turnover of glycoproteins</article-title>
          <source>EMBO J</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>1036</fpage>
          <lpage>1046</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hirsch C, Blom D, Ploegh HL (2003) A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J 22:1036&#x2013;1046 <pub-id pub-id-type="pmid">12606569</pub-id></citation>
      </ref>
      <ref id="CR49">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jarosch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum-associated protein degradation&#x2013;&#x2013;one model fits all?</article-title>
          <source>Biochim Biophys Acta Mol Cell Res</source>
          <year>2004</year>
          <volume>1695</volume>
          <fpage>215</fpage>
          <lpage>223</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hirsch C, Jarosch E, Sommer T, Wolf DH (2004) Endoplasmic reticulum-associated protein degradation&#x2013;&#x2013;one model fits all? Biochim Biophys Acta Mol Cell Res 1695:215&#x2013;223 </citation>
      </ref>
      <ref id="CR50">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hochstrasser</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ubiquitin-dependent protein degradation</article-title>
          <source>Annu Rev Genet</source>
          <year>1996</year>
          <volume>30</volume>
          <fpage>405</fpage>
          <lpage>439</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hochstrasser M (1996) Ubiquitin-dependent protein degradation. Annu Rev Genet 30:405&#x2013;439 <pub-id pub-id-type="pmid">8982460</pub-id></citation>
      </ref>
      <ref id="CR51">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yorihuzi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>LO</given-names>
            </name>
            <name>
              <surname>Herscovics</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation</article-title>
          <source>EMBO Rep</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>415</fpage>
          <lpage>422</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hosokawa N, Wada I, Hasegawa K, Yorihuzi T, Tremblay LO, Herscovics A, Nagata K (2001) A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation. EMBO Rep 2:415&#x2013;422 <pub-id pub-id-type="pmid">11375934</pub-id></citation>
      </ref>
      <ref id="CR52">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tremblay</surname>
              <given-names>LO</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Herscovics</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>26287</fpage>
          <lpage>26294</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hosokawa N, Tremblay LO, You Z, Herscovics A, Wada I, Nagata K (2003) Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I. J Biol Chem 278:26287&#x2013;26294 <pub-id pub-id-type="pmid">12736254</pub-id></citation>
      </ref>
      <ref id="CR53">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hosokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Natsuka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha 1-antitrypsin</article-title>
          <source>Genes Cells</source>
          <year>2006</year>
          <volume>11</volume>
          <fpage>465</fpage>
          <lpage>476</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hosokawa N, Wada I, Natsuka Y, Nagata K (2006) EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha 1-antitrypsin. Genes Cells 11:465&#x2013;476 <pub-id pub-id-type="pmid">16629899</pub-id></citation>
      </ref>
      <ref id="CR54">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hsu</surname>
              <given-names>VW</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Nuchtern</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Lippincott-Schwartz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hammerling</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Klausner</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules</article-title>
          <source>Nature</source>
          <year>1991</year>
          <volume>352</volume>
          <fpage>441</fpage>
          <lpage>444</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hsu VW, Yuan LC, Nuchtern JG, Lippincott-Schwartz J, Hammerling GJ, Klausner RD (1991) A recycling pathway between the endoplasmic reticulum and the Golgi apparatus for retention of unassembled MHC class I molecules. Nature 352:441&#x2013;444 <pub-id pub-id-type="pmid">1861723</pub-id></citation>
      </ref>
      <ref id="CR55">
        <citation citation-type="other">Hughes H, Stephens D (2008) Assembly, organization, and function of the COPII coat. Histochem Cell Biol 127. doi:10.1007/s00418-007-0363-x</citation>
      </ref>
      <ref id="CR56">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ismail</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Have you HRD? Understanding ERAD is DOAble!</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>237</fpage>
          <lpage>239</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ismail N, Ng DT (2006) Have you HRD? Understanding ERAD is DOAble! Cell 126:237&#x2013;239 <pub-id pub-id-type="pmid">16873052</pub-id></citation>
      </ref>
      <ref id="CR57">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Andrews</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Nonsecretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshworl cells and in aqueous humor</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>117</fpage>
          <lpage>125</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jacobson N, Andrews M, Shepard A (2001) Nonsecretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshworl cells and in aqueous humor. Hum Mol Genet 10:117&#x2013;125 <pub-id pub-id-type="pmid">11152659</pub-id></citation>
      </ref>
      <ref id="CR58">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jakob</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Burda</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aebi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Degradation of misfolded endoplasmic reticulum glycoproteins in <italic>Saccharomyces cerevisiae</italic> is determined by a specific oligosaccharide structure</article-title>
          <source>J Cell Biol</source>
          <year>1998</year>
          <volume>142</volume>
          <fpage>1223</fpage>
          <lpage>1233</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jakob CA, Burda P, Roth J, Aebi M (1998a) Degradation of misfolded endoplasmic reticulum glycoproteins in Saccharomyces cerevisiae is determined by a specific oligosaccharide structure. J Cell Biol 142:1223&#x2013;1233 <pub-id pub-id-type="pmid">9732283</pub-id></citation>
      </ref>
      <ref id="CR59">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jakob</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Burda</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>teHeesen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Aebi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Genetic tailoring of N-linked oligosaccharides: the role of glucose residues in glycoprotein processing of <italic>Saccharomyces cerevisiae in vivo</italic></article-title>
          <source>Glycobiology</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>155</fpage>
          <lpage>164</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jakob CA, Burda P, teHeesen S, Aebi M, Roth J (1998b) Genetic tailoring of N-linked oligosaccharides: the role of glucose residues in glycoprotein processing of Saccharomyces cerevisiae in vivo. Glycobiology 8:155&#x2013;164 <pub-id pub-id-type="pmid">9451025</pub-id></citation>
      </ref>
      <ref id="CR60">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jakob</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bodmer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Spirig</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Battig</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Marcil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dignard</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bergeron</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Aebi</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Htm1p, a mannosidase-like protein, is involved in glycoprotein degradation in yeast</article-title>
          <source>EMBO Rep</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>423</fpage>
          <lpage>430</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jakob CA, Bodmer D, Spirig U, Battig P, Marcil A, Dignard D, Bergeron JJ, Thomas DY, Aebi M (2001) Htm1p, a mannosidase-like protein, is involved in glycoprotein degradation in yeast. EMBO Rep 2:423&#x2013;430 <pub-id pub-id-type="pmid">11375935</pub-id></citation>
      </ref>
      <ref id="CR61">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarosch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Taxis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Volkwein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bordallo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Finley</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48</article-title>
          <source>Nat Cell Biol</source>
          <year>2002</year>
          <volume>4</volume>
          <fpage>134</fpage>
          <lpage>139</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, Wolf DH, Sommer T (2002) Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 4:134&#x2013;139 <pub-id pub-id-type="pmid">11813000</pub-id></citation>
      </ref>
      <ref id="CR62">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joe</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Sohn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hur</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>YR</given-names>
            </name>
            <name>
              <surname>Kee</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2003</year>
          <volume>312</volume>
          <fpage>592</fpage>
          <lpage>600</lpage>
        </citation>
        <citation citation-type="display-unstructured">Joe MK, Sohn S, Hur W, Moon Y, Choi YR, Kee C (2003) Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun 312:592&#x2013;600 <pub-id pub-id-type="pmid">14680806</pub-id></citation>
      </ref>
      <ref id="CR63">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnston</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Ward</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Aggresomes: a cellular response to misfolded proteins</article-title>
          <source>J Cell Biol</source>
          <year>1998</year>
          <volume>143</volume>
          <fpage>1883</fpage>
          <lpage>1898</lpage>
        </citation>
        <citation citation-type="display-unstructured">Johnston JA, Ward CL, Kopito RR (1998) Aggresomes: a cellular response to misfolded proteins. J Cell Biol 143:1883&#x2013;1898 <pub-id pub-id-type="pmid">9864362</pub-id></citation>
      </ref>
      <ref id="CR64">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnston</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dalton</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Gurney</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>12571</fpage>
          <lpage>12576</lpage>
        </citation>
        <citation citation-type="display-unstructured">Johnston JA, Dalton MJ, Gurney ME, Kopito RR (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97:12571&#x2013;12576 <pub-id pub-id-type="pmid">11050163</pub-id></citation>
      </ref>
      <ref id="CR65">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabashi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Durham</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
          <article-title>Failure of protein quality control in amyotrophic lateral sclerosis</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2006</year>
          <volume>1762</volume>
          <fpage>1038</fpage>
          <lpage>1050</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kabashi E, Durham HD (2006) Failure of protein quality control in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1038&#x2013;1050 <pub-id pub-id-type="pmid">16876390</pub-id></citation>
      </ref>
      <ref id="CR66">
        <citation citation-type="other">Kanehara K, Kawaguchi S, Ng DT (2007) The EDEM and Yos9p families of lectin-like ERAD factors. Semin Cell Dev Biol. doi:10.1016/j.semcdb.2007.09.007</citation>
      </ref>
      <ref id="CR67">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katiyar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Joshi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lennarz</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>The retrotranslocation protein derlin-1 binds Peptide: <italic>N</italic>-glycanase to the endoplasmic reticulum</article-title>
          <source>Mol Biol Cell</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>4584</fpage>
          <lpage>4594</lpage>
        </citation>
        <citation citation-type="display-unstructured">Katiyar S, Joshi S, Lennarz WJ (2005) The retrotranslocation protein derlin-1 binds Peptide: N-glycanase to the endoplasmic reticulum. Mol Biol Cell 16:4584&#x2013;4594 <pub-id pub-id-type="pmid">16055502</pub-id></citation>
      </ref>
      <ref id="CR68">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kawaguchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kovacs</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>McLaurin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vance</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>TP</given-names>
            </name>
          </person-group>
          <article-title>The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>115</volume>
          <fpage>727</fpage>
          <lpage>738</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP (2003) The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115:727&#x2013;738 <pub-id pub-id-type="pmid">14675537</pub-id></citation>
      </ref>
      <ref id="CR69">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Arvan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones</article-title>
          <source>Endocr Rev</source>
          <year>1998</year>
          <volume>19</volume>
          <fpage>173</fpage>
          <lpage>202</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim PS, Arvan P (1998) Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 19:173&#x2013;202 <pub-id pub-id-type="pmid">9570036</pub-id></citation>
      </ref>
      <ref id="CR70">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>OY</given-names>
            </name>
            <name>
              <surname>Arvan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism</article-title>
          <source>J Cell Biol</source>
          <year>1996</year>
          <volume>133</volume>
          <fpage>517</fpage>
          <lpage>527</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim PS, Kwon OY, Arvan P (1996) An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol 133:517&#x2013;527 <pub-id pub-id-type="pmid">8636228</pub-id></citation>
      </ref>
      <ref id="CR71">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Arvan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>9909</fpage>
          <lpage>9913</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim PS, Hossain SA, Park YN, Lee I, Yoo SE, Arvan P (1998) A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci USA 95:9909&#x2013;9913 <pub-id pub-id-type="pmid">9707574</pub-id></citation>
      </ref>
      <ref id="CR72">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Miyamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Agui</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A missense mutation G2320R in the thyroglobulin gene causes nongoitrous congenital primary hypothyroidism in the WIC-rdw rat</article-title>
          <source>Mol Endocrinol</source>
          <year>2000</year>
          <volume>14</volume>
          <fpage>1944</fpage>
          <lpage>1953</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim PS, Ding M, Menon S, Jung CG, Cheng JM, Miyamoto T, Li BL, Agui T (2000) A missense mutation G2320R in the thyroglobulin gene causes nongoitrous congenital primary hypothyroidism in the WIC-rdw rat. Mol Endocrinol 14:1944&#x2013;1953 <pub-id pub-id-type="pmid">11117525</pub-id></citation>
      </ref>
      <ref id="CR73">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis and degradation of CFTR</article-title>
          <source>Physiol Rev</source>
          <year>1999</year>
          <volume>79</volume>
          <fpage>S167</fpage>
          <lpage>173</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kopito RR (1999) Biosynthesis and degradation of CFTR. Physiol Rev 79:S167&#x2013;173 <pub-id pub-id-type="pmid">9922380</pub-id></citation>
      </ref>
      <ref id="CR74">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kopito</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Conformation disease</article-title>
          <source>Nat Cell Biol</source>
          <year>2000</year>
          <volume>2</volume>
          <fpage>E207</fpage>
          <lpage>E209</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kopito R (2000) Conformation disease. Nat Cell Biol 2:E207&#x2013;E209 <pub-id pub-id-type="pmid">11056553</pub-id></citation>
      </ref>
      <ref id="CR75">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Sitia</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Aggresomes and Russell bodies. Symptoms of cellular indigestion?</article-title>
          <source>EMBO Rep</source>
          <year>2000</year>
          <volume>1</volume>
          <fpage>225</fpage>
          <lpage>231</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kopito RR, Sitia R (2000) Aggresomes and Russell bodies. Symptoms of cellular indigestion? EMBO Rep 1:225&#x2013;231 <pub-id pub-id-type="pmid">11256604</pub-id></citation>
      </ref>
      <ref id="CR76">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostova</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Importance of carbohydrate positioning in the recognition of mutated CPY for ER-associated degradation</article-title>
          <source>J Cell Sci</source>
          <year>2005</year>
          <volume>118</volume>
          <fpage>1485</fpage>
          <lpage>1492</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kostova Z, Wolf DH (2005) Importance of carbohydrate positioning in the recognition of mutated CPY for ER-associated degradation. J Cell Sci 118:1485&#x2013;1492 <pub-id pub-id-type="pmid">15769847</pub-id></citation>
      </ref>
      <ref id="CR77">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lehrman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Elhammer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Russell</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum</article-title>
          <source>J Biol Chem</source>
          <year>1987</year>
          <volume>262</volume>
          <fpage>401</fpage>
          <lpage>410</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lehrman MA, Schneider WJ, Brown MS, Davis CG, Elhammer A, Russell DW, Goldstein JL (1987) The Lebanese allele at the low density lipoprotein receptor locus. Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum. J Biol Chem 262:401&#x2013;410 <pub-id pub-id-type="pmid">3025214</pub-id></citation>
      </ref>
      <ref id="CR78">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>XK</given-names>
            </name>
            <name>
              <surname>Schindelin</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lennarz</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>The AAA ATPase p97 links peptide <italic>N</italic>-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>8348</fpage>
          <lpage>8353</lpage>
        </citation>
        <citation citation-type="display-unstructured">Li GT, Zhao G, Zhou XK, Schindelin H, Lennarz WJ (2006) The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor. Proc Natl Acad Sci USA 103:8348&#x2013;8353 <pub-id pub-id-type="pmid">16709668</pub-id></citation>
      </ref>
      <ref id="CR79">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lilley</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Ploegh</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>A membrane protein required for dislocation of misfolded proteins from the ER</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>429</volume>
          <fpage>834</fpage>
          <lpage>840</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lilley BN, Ploegh HL (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429:834&#x2013;840 <pub-id pub-id-type="pmid">15215855</pub-id></citation>
      </ref>
      <ref id="CR80">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McKenzie</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Floyd</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zeitlin</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids</article-title>
          <source>Am J Respir Cell Mol Biol</source>
          <year>2004</year>
          <volume>31</volume>
          <fpage>351</fpage>
          <lpage>357</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lim M, McKenzie K, Floyd AD, Kwon E, Zeitlin PL (2004) Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids. Am J Respir Cell Mol Biol 31:351&#x2013;357 <pub-id pub-id-type="pmid">15191910</pub-id></citation>
      </ref>
      <ref id="CR81">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindholm</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wootz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Korhonen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>ER stress and neurodegenerative diseases</article-title>
          <source>Cell Death Differ</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>385</fpage>
          <lpage>392</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ 13:385&#x2013;392 <pub-id pub-id-type="pmid">16397584</pub-id></citation>
      </ref>
      <ref id="CR82">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Choudhury</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Sifers</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome</article-title>
          <source>J Biol Chem</source>
          <year>1999</year>
          <volume>274</volume>
          <fpage>5861</fpage>
          <lpage>5867</lpage>
        </citation>
        <citation citation-type="display-unstructured">Liu Y, Choudhury P, Cabral CM, Sifers RN (1999) Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome. J Biol Chem 274:5861&#x2013;5867 <pub-id pub-id-type="pmid">10026209</pub-id></citation>
      </ref>
      <ref id="CR83">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Done</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kilpelainen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Pikkarainen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tryggvason</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Defective trafficking of nephrin missense mutants rescued by a chemical chaperone</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>1731</fpage>
          <lpage>1738</lpage>
        </citation>
        <citation citation-type="display-unstructured">Liu XL, Done SC, Yan K, Kilpelainen P, Pikkarainen T, Tryggvason K (2004) Defective trafficking of nephrin missense mutants rescued by a chemical chaperone. J Am Soc Nephrol 15:1731&#x2013;1738 <pub-id pub-id-type="pmid">15213260</pub-id></citation>
      </ref>
      <ref id="CR84">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lomas</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Alpha1-antitrypsin deficiency. 4: molecular pathophysiology</article-title>
          <source>Thorax</source>
          <year>2004</year>
          <volume>59</volume>
          <fpage>529</fpage>
          <lpage>535</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lomas DA, Parfrey H (2004) Alpha1-antitrypsin deficiency. 4: molecular pathophysiology. Thorax 59:529&#x2013;535 <pub-id pub-id-type="pmid">15170041</pub-id></citation>
      </ref>
      <ref id="CR85">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lomas</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Finch</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Carrell</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>The mechanism of Z alpha 1-antitrypsin accumulation in the liver</article-title>
          <source>Nature</source>
          <year>1992</year>
          <volume>357</volume>
          <fpage>605</fpage>
          <lpage>607</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lomas DA, Evans DL, Finch JT, Carrell RW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357:605&#x2013;607 <pub-id pub-id-type="pmid">1608473</pub-id></citation>
      </ref>
      <ref id="CR86">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lomas</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Belorgey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Mallya</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Onda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kinghorn</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Crowther</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies</article-title>
          <source>Front Biosci</source>
          <year>2004</year>
          <volume>9</volume>
          <fpage>2873</fpage>
          <lpage>2891</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lomas DA, Belorgey D, Mallya M, Onda M, Kinghorn KJ, Sharp LK, Phillips RL, Page R, Crowther DC, Miranda E (2004) Polymerisation underlies alpha1-antitrypsin deficiency, dementia and other serpinopathies. Front Biosci 9:2873&#x2013;2891 <pub-id pub-id-type="pmid">15353322</pub-id></citation>
      </ref>
      <ref id="CR87">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubas</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Golgi endo-alpha-<sc>d</sc>-mannosidase from rat liver, a novel N-linked carbohydrate unit processing enzyme</article-title>
          <source>J Biol Chem</source>
          <year>1987</year>
          <volume>262</volume>
          <fpage>3775</fpage>
          <lpage>3781</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lubas WA, Spiro RG (1987) Golgi endo-alpha-d-mannosidase from rat liver, a novel N-linked carbohydrate unit processing enzyme. J Biol Chem 262:3775&#x2013;3781 <pub-id pub-id-type="pmid">3818665</pub-id></citation>
      </ref>
      <ref id="CR88">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubas</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the role of rat liver Golgi endo-alpha-<sc>d</sc>-mannosidase in processing N-linked oligosaccharides</article-title>
          <source>J Biol Chem</source>
          <year>1988</year>
          <volume>263</volume>
          <fpage>3990</fpage>
          <lpage>3998</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lubas WA, Spiro RG (1988) Evaluation of the role of rat liver Golgi endo-alpha-d-mannosidase in processing N-linked oligosaccharides. J Biol Chem 263:3990&#x2013;3998 <pub-id pub-id-type="pmid">3346233</pub-id></citation>
      </ref>
      <ref id="CR89">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucocq</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Brada</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Immunolocalization of the oligosaccharide trimming enzyme glucosidase II</article-title>
          <source>J Cell Biol</source>
          <year>1986</year>
          <volume>102</volume>
          <fpage>2137</fpage>
          <lpage>2146</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lucocq JM, Brada D, Roth J (1986) Immunolocalization of the oligosaccharide trimming enzyme glucosidase II. J Cell Biol 102:2137&#x2013;2146 <pub-id pub-id-type="pmid">3519622</pub-id></citation>
      </ref>
      <ref id="CR90">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lukacs</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Mohamed</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kartner</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>XB</given-names>
            </name>
            <name>
              <surname>Riordan</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Grinstein</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP</article-title>
          <source>EMBO J</source>
          <year>1994</year>
          <volume>13</volume>
          <fpage>6076</fpage>
          <lpage>6086</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR, Grinstein S (1994) Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J 13:6076&#x2013;6086 <pub-id pub-id-type="pmid">7529176</pub-id></citation>
      </ref>
      <ref id="CR91">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matsuda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Oshima</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takimoto</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yasuda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemical chaperone therapy for brain pathology in G<sub>M1</sub>-gangliosidosis</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>15912</fpage>
          <lpage>15917</lpage>
        </citation>
        <citation citation-type="display-unstructured">Matsuda J, Suzuki O, Oshima A, Yamamoto Y, Noguchi A, Takimoto K, Itoh M, Matsuzaki Y, Yasuda Y, Ogawa S et al (2003) Chemical chaperone therapy for brain pathology in GM1-gangliosidosis. Proc Natl Acad Sci USA 100:15912&#x2013;15917 <pub-id pub-id-type="pmid">14676316</pub-id></citation>
      </ref>
      <ref id="CR92">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mattioli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Anelli</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fagioli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tacchetti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sitia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Valetti</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies</article-title>
          <source>J Cell Sci</source>
          <year>2006</year>
          <volume>119</volume>
          <fpage>2532</fpage>
          <lpage>2541</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mattioli L, Anelli T, Fagioli C, Tacchetti C, Sitia R, Valetti C (2006) ER storage diseases: a role for ERGIC-53 in controlling the formation and shape of Russell bodies. J Cell Sci 119:2532&#x2013;2541 <pub-id pub-id-type="pmid">16735443</pub-id></citation>
      </ref>
      <ref id="CR93">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCracken</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Brodsky</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Recognition and delivery of ERAD substrates to the proteasome and alternative paths for cell survival</article-title>
          <source>Curr Top Microbiol Immunol</source>
          <year>2005</year>
          <volume>300</volume>
          <fpage>17</fpage>
          <lpage>40</lpage>
        </citation>
        <citation citation-type="display-unstructured">McCracken AA, Brodsky JL (2005) Recognition and delivery of ERAD substrates to the proteasome and alternative paths for cell survival. Curr Top Microbiol Immunol 300:17&#x2013;40 <pub-id pub-id-type="pmid">16573235</pub-id></citation>
      </ref>
      <ref id="CR94">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNaught</surname>
              <given-names>KSP</given-names>
            </name>
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Halliwell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Isacson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jenner</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Failure of the ubiquitin&#x2013;proteasome system in Parkinson&#x2019;s disease</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>589</fpage>
          <lpage>594</lpage>
        </citation>
        <citation citation-type="display-unstructured">McNaught KSP, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin&#x2013;proteasome system in Parkinson&#x2019;s disease. Nat Rev Neurosci 2:589&#x2013;594 <pub-id pub-id-type="pmid">11484002</pub-id></citation>
      </ref>
      <ref id="CR95">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNaught</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Mytilineou</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>JnoBaptiste</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yabut</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shashidharan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jenner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Impairment of the ubiquitin&#x2013;proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures</article-title>
          <source>J Neurochem</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>301</fpage>
          <lpage>306</lpage>
        </citation>
        <citation citation-type="display-unstructured">McNaught KS, Mytilineou C, JnoBaptiste R, Yabut J, Shashidharan P, Jenner P, Olanow CW (2002a) Impairment of the ubiquitin&#x2013;proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J Neurochem 81:301&#x2013;306 <pub-id pub-id-type="pmid">12064477</pub-id></citation>
      </ref>
      <ref id="CR96">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNaught</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Shashidharan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Perl</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Jenner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Aggresome-related biogenesis of Lewy bodies</article-title>
          <source>Eur J Neurosci</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>2136</fpage>
          <lpage>2148</lpage>
        </citation>
        <citation citation-type="display-unstructured">McNaught KS, Shashidharan P, Perl DP, Jenner P, Olanow CW (2002b) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136&#x2013;2148 <pub-id pub-id-type="pmid">12473081</pub-id></citation>
      </ref>
      <ref id="CR97">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNaught</surname>
              <given-names>KSP</given-names>
            </name>
            <name>
              <surname>Shashidharan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Perl</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Jenner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Aggresome-related biogenesis of Lewy bodies</article-title>
          <source>Eur J Neurosci</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>2136</fpage>
          <lpage>2148</lpage>
        </citation>
        <citation citation-type="display-unstructured">McNaught KSP, Shashidharan P, Perl DP, Jenner P, Olanow CW (2002c) Aggresome-related biogenesis of Lewy bodies. Eur J Neurosci 16:2136&#x2013;2148 <pub-id pub-id-type="pmid">12473081</pub-id></citation>
      </ref>
      <ref id="CR98">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McNaught</surname>
              <given-names>KSP</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>JnoBaptiste</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kapustin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Proteasomal dysfunction in sporadic Parkinson&#x2019;s disease</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>66</volume>
          <fpage>S37</fpage>
          <lpage>S49</lpage>
        </citation>
        <citation citation-type="display-unstructured">McNaught KSP, Jackson T, JnoBaptiste R, Kapustin A, Olanow CW (2006) Proteasomal dysfunction in sporadic Parkinson&#x2019;s disease. Neurology 66:S37&#x2013;S49 <pub-id pub-id-type="pmid">16717251</pub-id></citation>
      </ref>
      <ref id="CR99">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Medeiros Neto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Vono</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Targovnik</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Camargo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hossain</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Arvan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Congenital hypothyroid goiter with deficient thyroglobulin&#x2013;&#x2013;identification of an endoplasmic reticulum storage disease with induction of molecular chaperones</article-title>
          <source>J Clin Invest</source>
          <year>1996</year>
          <volume>98</volume>
          <fpage>2838</fpage>
          <lpage>2844</lpage>
        </citation>
        <citation citation-type="display-unstructured">Medeiros Neto G, Kim PS, Yoo SE, Vono J, Targovnik HM, Camargo R, Hossain SA, Arvan P (1996) Congenital hypothyroid goiter with deficient thyroglobulin&#x2013;&#x2013;identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 98:2838&#x2013;2844 <pub-id pub-id-type="pmid">8981932</pub-id></citation>
      </ref>
      <ref id="CR100">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meusser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jarosch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>ERAD: the long road to destruction</article-title>
          <source>Nat Cell Biol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>766</fpage>
          <lpage>772</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meusser B, Hirsch C, Jarosch E, Sommer T (2005) ERAD: the long road to destruction. Nat Cell Biol 7:766&#x2013;772 <pub-id pub-id-type="pmid">16056268</pub-id></citation>
      </ref>
      <ref id="CR101">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Molinari</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Calanca</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Galli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lucca</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Paganetti</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>1397</fpage>
          <lpage>1400</lpage>
        </citation>
        <citation citation-type="display-unstructured">Molinari M, Calanca V, Galli C, Lucca P, Paganetti P (2003) Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299:1397&#x2013;1400 <pub-id pub-id-type="pmid">12610306</pub-id></citation>
      </ref>
      <ref id="CR102">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Demonstration that Golgi endo-&#x3B1;-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins</article-title>
          <source>J Biol Chem</source>
          <year>1990</year>
          <volume>265</volume>
          <fpage>13104</fpage>
          <lpage>13112</lpage>
        </citation>
        <citation citation-type="display-unstructured">Moore SE, Spiro RG (1990) Demonstration that Golgi endo-&#x3B1;-mannosidase provides a glucosidase-independent pathway for the formation of complex N-linked oligosaccharides of glycoproteins. J Biol Chem 265:13104&#x2013;13112 <pub-id pub-id-type="pmid">2165493</pub-id></citation>
      </ref>
      <ref id="CR103">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the endomannosidase pathway for the processing of N-linked oligosaccharides in glucosidase II-deficient and parent mouse lymphoma cells</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>8443</fpage>
          <lpage>8451</lpage>
        </citation>
        <citation citation-type="display-unstructured">Moore SE, Spiro RG (1992) Characterization of the endomannosidase pathway for the processing of N-linked oligosaccharides in glucosidase II-deficient and parent mouse lymphoma cells. J Biol Chem 267:8443&#x2013;8451 <pub-id pub-id-type="pmid">1533222</pub-id></citation>
      </ref>
      <ref id="CR104">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morello</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bichet</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Nephrogenic diabetes insipidus</article-title>
          <source>Annu Rev Physiol</source>
          <year>2001</year>
          <volume>63</volume>
          <fpage>607</fpage>
          <lpage>630</lpage>
        </citation>
        <citation citation-type="display-unstructured">Morello JP, Bichet DG (2001) Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607&#x2013;630 <pub-id pub-id-type="pmid">11181969</pub-id></citation>
      </ref>
      <ref id="CR105">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakatsukasa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nishikawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hosokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Endo</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mnl1p, an alpha-mannosidase-like protein in yeast <italic>Saccharomyces cerevisiae</italic>, is required for endoplasmic reticulum-associated degradation of glycoproteins</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>8635</fpage>
          <lpage>8638</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nakatsukasa K, Nishikawa S, Hosokawa N, Nagata K, Endo T (2001) Mnl1p, an alpha-mannosidase-like protein in yeast Saccharomyces cerevisiae, is required for endoplasmic reticulum-associated degradation of glycoproteins. J Biol Chem 276:8635&#x2013;8638 <pub-id pub-id-type="pmid">11254655</pub-id></citation>
      </ref>
      <ref id="CR106">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neuber</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Jarosch</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Volkwein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sommer</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Ubx2 links the Cdc48 complex to ER-associated protein degradation</article-title>
          <source>Nat Cell Biol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>993</fpage>
          <lpage>998</lpage>
        </citation>
        <citation citation-type="display-unstructured">Neuber O, Jarosch E, Volkwein C, Walter J, Sommer T (2005) Ubx2 links the Cdc48 complex to ER-associated protein degradation. Nat Cell Biol 7:993&#x2013;998 <pub-id pub-id-type="pmid">16179953</pub-id></citation>
      </ref>
      <ref id="CR107">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hosokawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wada</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin</article-title>
          <source>Science</source>
          <year>2003</year>
          <volume>299</volume>
          <fpage>1394</fpage>
          <lpage>1397</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oda Y, Hosokawa N, Wada I, Nagata K (2003) EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin. Science 299:1394&#x2013;1397 <pub-id pub-id-type="pmid">12610305</pub-id></citation>
      </ref>
      <ref id="CR108">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kaufman</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Nagata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation</article-title>
          <source>J Cell Biol</source>
          <year>2006</year>
          <volume>172</volume>
          <fpage>383</fpage>
          <lpage>393</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oda Y, Okada T, Yoshida H, Kaufman RJ, Nagata K, Mori K (2006) Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J Cell Biol 172:383&#x2013;393 <pub-id pub-id-type="pmid">16449189</pub-id></citation>
      </ref>
      <ref id="CR109">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olanow</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Perl</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>DeMartino</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>McNaught</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Lewy-body formation is an aggresome-related process: a hypothesis</article-title>
          <source>Lancet Neurol</source>
          <year>2004</year>
          <volume>3</volume>
          <fpage>496</fpage>
          <lpage>503</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olanow CW, Perl DP, DeMartino GN, McNaught KS (2004) Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol 3:496&#x2013;503 <pub-id pub-id-type="pmid">15261611</pub-id></citation>
      </ref>
      <ref id="CR110">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Olivari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Galli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alanen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ruddock</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Molinari</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>2424</fpage>
          <lpage>2428</lpage>
        </citation>
        <citation citation-type="display-unstructured">Olivari S, Galli C, Alanen H, Ruddock L, Molinari M (2005) A novel stress-induced EDEM variant regulating endoplasmic reticulum-associated glycoprotein degradation. J Biol Chem 280:2424&#x2013;2428 <pub-id pub-id-type="pmid">15579471</pub-id></citation>
      </ref>
      <ref id="CR111">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oyadomari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells</article-title>
          <source>Apoptosis</source>
          <year>2002</year>
          <volume>7</volume>
          <fpage>335</fpage>
          <lpage>345</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oyadomari S, Araki E, Mori M (2002a) Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7:335&#x2013;345 <pub-id pub-id-type="pmid">12101393</pub-id></citation>
      </ref>
      <ref id="CR112">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oyadomari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koizumi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Gotoh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Akira</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Araki</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes</article-title>
          <source>J Clin Invest</source>
          <year>2002</year>
          <volume>109</volume>
          <fpage>525</fpage>
          <lpage>532</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E, Mori M (2002b) Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. J Clin Invest 109:525&#x2013;532 <pub-id pub-id-type="pmid">11854325</pub-id></citation>
      </ref>
      <ref id="CR113">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palade</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Intracisternal granules in the exocrine cells of the pancreas</article-title>
          <source>J Biophys Biochem Cytol</source>
          <year>1956</year>
          <volume>2</volume>
          <fpage>417</fpage>
          <lpage>422</lpage>
        </citation>
        <citation citation-type="display-unstructured">Palade G (1956) Intracisternal granules in the exocrine cells of the pancreas. J Biophys Biochem Cytol 2:417&#x2013;422 <pub-id pub-id-type="pmid">13357506</pub-id></citation>
      </ref>
      <ref id="CR114">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Palade</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Intracellular aspects of the process of protein biosynthesis</article-title>
          <source>Science</source>
          <year>1975</year>
          <volume>189</volume>
          <fpage>347</fpage>
          <lpage>358</lpage>
        </citation>
        <citation citation-type="display-unstructured">Palade G (1975) Intracellular aspects of the process of protein biosynthesis. Science 189:347&#x2013;358 <pub-id pub-id-type="pmid">1096303</pub-id></citation>
      </ref>
      <ref id="CR115">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papp</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Csermely</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Chemical chaperones: mechanisms of action and potential use</article-title>
          <source>Handb Exp Pharmacol</source>
          <year>2006</year>
          <volume>172</volume>
          <fpage>405</fpage>
          <lpage>416</lpage>
        </citation>
        <citation citation-type="display-unstructured">Papp E, Csermely P (2006) Chemical chaperones: mechanisms of action and potential use. Handb Exp Pharmacol 172:405&#x2013;416 <pub-id pub-id-type="pmid">16610368</pub-id></citation>
      </ref>
      <ref id="CR116">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Bolender</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Eisele</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kostova</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coffino</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>The cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin&#x2013;proteasome system</article-title>
          <source>Mol Biol Cell</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>153</fpage>
          <lpage>165</lpage>
        </citation>
        <citation citation-type="display-unstructured">Park SH, Bolender N, Eisele F, Kostova Z, Takeuchi J, Coffino P, Wolf DH (2007) The cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin&#x2013;proteasome system. Mol Biol Cell 18:153&#x2013;165 <pub-id pub-id-type="pmid">17065559</pub-id></citation>
      </ref>
      <ref id="CR117">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parodi</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Protein glucosylation and its role in protein folding</article-title>
          <source>Annu Rev Biochem</source>
          <year>2000</year>
          <volume>69</volume>
          <fpage>69</fpage>
          <lpage>93</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parodi AJ (2000) Protein glucosylation and its role in protein folding. Annu Rev Biochem 69:69&#x2013;93 <pub-id pub-id-type="pmid">10966453</pub-id></citation>
      </ref>
      <ref id="CR118">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parodi</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Mendelzon</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Lederkremer</surname>
              <given-names>GZ</given-names>
            </name>
          </person-group>
          <article-title>Transient glucosylation of protein-bound Man9GlcNAc2, Man8GlcNAc2, and Man7GlcNAc2 in calf thyroid cells. A possible recognition signal in the processing of glycoproteins</article-title>
          <source>J Biol Chem</source>
          <year>1983</year>
          <volume>258</volume>
          <fpage>8260</fpage>
          <lpage>8265</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parodi AJ, Mendelzon DH, Lederkremer GZ (1983) Transient glucosylation of protein-bound Man9GlcNAc2, Man8GlcNAc2, and Man7GlcNAc2 in calf thyroid cells. A possible recognition signal in the processing of glycoproteins. J Biol Chem 258:8260&#x2013;8265 <pub-id pub-id-type="pmid">6863289</pub-id></citation>
      </ref>
      <ref id="CR119">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pathak</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Merkle</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>RGW</given-names>
            </name>
          </person-group>
          <article-title>Immunocytochemical localization of mutant low density lipoprotein receptors that fail to reach the Golgi complex</article-title>
          <source>J Cell Biol</source>
          <year>1988</year>
          <volume>106</volume>
          <fpage>1831</fpage>
          <lpage>1841</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pathak RK, Merkle RK, Cummings RD, Goldstein JL, Brown MS, Anderson RGW (1988) Immunocytochemical localization of mutant low density lipoprotein receptors that fail to reach the Golgi complex. J Cell Biol 106:1831&#x2013;1841 <pub-id pub-id-type="pmid">2898477</pub-id></citation>
      </ref>
      <ref id="CR120">
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Pavelka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Functional ultrastructure. An Atlas of tissue biology and pathology</source>
          <year>2005</year>
          <publisher-loc>Vienna</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </citation>
        <citation citation-type="display-unstructured">Pavelka M, Roth J (2005) Functional ultrastructure. An Atlas of tissue biology and pathology. Springer, Vienna </citation>
      </ref>
      <ref id="CR121">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pedemonte</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lukacs</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Caci</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zegarra-Moran</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Galietta</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Verkman</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening</article-title>
          <source>J Clin Invest</source>
          <year>2005</year>
          <volume>115</volume>
          <fpage>2564</fpage>
          <lpage>2571</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJ, Verkman AS (2005) Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Invest 115:2564&#x2013;2571 <pub-id pub-id-type="pmid">16127463</pub-id></citation>
      </ref>
      <ref id="CR122">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pelletier</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Marcil</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sevigny</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jakob</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Tessier</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Chevet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Menard</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bergeron</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>DY</given-names>
            </name>
          </person-group>
          <article-title>The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo</article-title>
          <source>Glycobiology</source>
          <year>2000</year>
          <volume>10</volume>
          <fpage>815</fpage>
          <lpage>827</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pelletier MF, Marcil A, Sevigny G, Jakob CA, Tessier DC, Chevet E, Menard R, Bergeron JJ, Thomas DY (2000) The heterodimeric structure of glucosidase II is required for its activity, solubility, and localization in vivo. Glycobiology 10:815&#x2013;827 <pub-id pub-id-type="pmid">10929008</pub-id></citation>
      </ref>
      <ref id="CR123">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perlmutter</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking</article-title>
          <source>Pediat Res</source>
          <year>2002</year>
          <volume>52</volume>
          <fpage>832</fpage>
          <lpage>836</lpage>
        </citation>
        <citation citation-type="display-unstructured">Perlmutter DH (2002) Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediat Res 52:832&#x2013;836 <pub-id pub-id-type="pmid">12438657</pub-id></citation>
      </ref>
      <ref id="CR124">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pet&#xE4;j&#xE4;-Repo</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Hogue</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laperri&#xE8;re</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Walkers</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bouvier</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human &#x3B4; opiod receptor</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>13727</fpage>
          <lpage>13736</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pet&#xE4;j&#xE4;-Repo U, Hogue M, Laperri&#xE8;re A, Walkers P, Bouvier M (2000) Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human &#x3B4; opiod receptor. J Biol Chem 275:13727&#x2013;13736 <pub-id pub-id-type="pmid">10788493</pub-id></citation>
      </ref>
      <ref id="CR125">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pet&#xE4;j&#xE4;-Repo</surname>
              <given-names>UE</given-names>
            </name>
            <name>
              <surname>Hogue</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bhalla</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Laperriere</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morello</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Bouvier</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation</article-title>
          <source>EMBO J</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>1628</fpage>
          <lpage>1637</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pet&#xE4;j&#xE4;-Repo UE, Hogue M, Bhalla S, Laperriere A, Morello JP, Bouvier M (2002) Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21:1628&#x2013;1637 <pub-id pub-id-type="pmid">11927547</pub-id></citation>
      </ref>
      <ref id="CR126">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabouille</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Nonselective utilization of the endomannosidase pathway for processing glycoproteins by human hepatoma (HepG2) cells</article-title>
          <source>J Biol Chem</source>
          <year>1992</year>
          <volume>267</volume>
          <fpage>11573</fpage>
          <lpage>11578</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rabouille C, Spiro RG (1992) Nonselective utilization of the endomannosidase pathway for processing glycoproteins by human hepatoma (HepG2) cells. J Biol Chem 267:11573&#x2013;11578 <pub-id pub-id-type="pmid">1317871</pub-id></citation>
      </ref>
      <ref id="CR127">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raposo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>van</surname>
              <given-names>S-HM</given-names>
            </name>
            <name>
              <surname>Leijendekker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Geuze</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Ploegh</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER&#x2013;Golgi intermediate compartment</article-title>
          <source>J Cell Biol</source>
          <year>1995</year>
          <volume>131</volume>
          <fpage>1403</fpage>
          <lpage>1419</lpage>
        </citation>
        <citation citation-type="display-unstructured">Raposo G, van S-HM, Leijendekker R, Geuze HJ, Ploegh HL (1995) Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER&#x2013;Golgi intermediate compartment. J Cell Biol 131:1403&#x2013;1419 <pub-id pub-id-type="pmid">8522600</pub-id></citation>
      </ref>
      <ref id="CR128">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ravid</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kreft</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Hochstrasser</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways</article-title>
          <source>Embo J</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>533</fpage>
          <lpage>543</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ravid T, Kreft SG, Hochstrasser M (2006) Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways. Embo J 25:533&#x2013;543 <pub-id pub-id-type="pmid">16437165</pub-id></citation>
      </ref>
      <ref id="CR129">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riordan</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein</article-title>
          <source>Am J Hum Genet</source>
          <year>1999</year>
          <volume>64</volume>
          <fpage>1499</fpage>
          <lpage>1504</lpage>
        </citation>
        <citation citation-type="display-unstructured">Riordan JR (1999) Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. Am J Hum Genet 64:1499&#x2013;1504 <pub-id pub-id-type="pmid">10330337</pub-id></citation>
      </ref>
      <ref id="CR130">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Protein <italic>N</italic>-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions</article-title>
          <source>Chem Rev</source>
          <year>2002</year>
          <volume>102</volume>
          <fpage>285</fpage>
          <lpage>303</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roth J (2002) Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102:285&#x2013;303 <pub-id pub-id-type="pmid">11841244</pub-id></citation>
      </ref>
      <ref id="CR131">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Guhl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The importance of trimming reactions on asparagine-linked oligosaccharides for protein quality control</article-title>
          <source>Histochem Cell Biol</source>
          <year>2002</year>
          <volume>117</volume>
          <fpage>159</fpage>
          <lpage>169</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roth J, Zuber C, Guhl B, Fan JY, Ziak M (2002) The importance of trimming reactions on asparagine-linked oligosaccharides for protein quality control. Histochem Cell Biol 117:159&#x2013;169 <pub-id pub-id-type="pmid">11935292</pub-id></citation>
      </ref>
      <ref id="CR132">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The role of glucosidase II and endomannosidase in glucose trimming of asparagine-linked oligosaccharides</article-title>
          <source>Biochimie</source>
          <year>2003</year>
          <volume>85</volume>
          <fpage>287</fpage>
          <lpage>294</lpage>
        </citation>
        <citation citation-type="display-unstructured">Roth J, Ziak M, Zuber C (2003) The role of glucosidase II and endomannosidase in glucose trimming of asparagine-linked oligosaccharides. Biochimie 85:287&#x2013;294 <pub-id pub-id-type="pmid">12770767</pub-id></citation>
      </ref>
      <ref id="CR133">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubinsztein</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>The roles of intracellular protein-degradation pathways in neurodegeneration</article-title>
          <source>Nature</source>
          <year>2006</year>
          <volume>443</volume>
          <fpage>780</fpage>
          <lpage>786</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rubinsztein DC (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443:780&#x2013;786 <pub-id pub-id-type="pmid">17051204</pub-id></citation>
      </ref>
      <ref id="CR134">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubenstein</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Zeitlin</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2000</year>
          <volume>278</volume>
          <fpage>C259</fpage>
          <lpage>267</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rubenstein RC, Zeitlin PL (2000) Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am J Physiol Cell Physiol 278:C259&#x2013;267 <pub-id pub-id-type="pmid">10666020</pub-id></citation>
      </ref>
      <ref id="CR135">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saraste</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Palade</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Farquhar</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Antibodies to rat pancreas Golgi subfractions: identification of a 58-kD cis-Golgi protein</article-title>
          <source>J Cell Biol</source>
          <year>1987</year>
          <volume>105</volume>
          <fpage>2021</fpage>
          <lpage>2029</lpage>
        </citation>
        <citation citation-type="display-unstructured">Saraste J, Palade G, Farquhar M (1987) Antibodies to rat pancreas Golgi subfractions: identification of a 58-kD cis-Golgi protein. J Cell Biol 105:2021&#x2013;2029 <pub-id pub-id-type="pmid">3316245</pub-id></citation>
      </ref>
      <ref id="CR136">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sawkar</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Beutler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Balch</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>15428</fpage>
          <lpage>15433</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sawkar AR, Cheng WC, Beutler E, Wong CH, Balch WE, Kelly JW (2002) Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease. Proc Natl Acad Sci USA 99:15428&#x2013;15433 <pub-id pub-id-type="pmid">12434014</pub-id></citation>
      </ref>
      <ref id="CR137">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sayeed</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Search and destroy: ER quality control and ER-associated protein degradation</article-title>
          <source>Crit Rev Biochem Mol Biol</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>75</fpage>
          <lpage>91</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sayeed A, Ng DT (2005) Search and destroy: ER quality control and ER-associated protein degradation. Crit Rev Biochem Mol Biol 40:75&#x2013;91 <pub-id pub-id-type="pmid">15814429</pub-id></citation>
      </ref>
      <ref id="CR138">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuberth</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Buchberger</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation</article-title>
          <source>Nat Cell Biol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>999</fpage>
          <lpage>1006</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schuberth C, Buchberger A (2005) Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation. Nat Cell Biol 7:999&#x2013;1006 <pub-id pub-id-type="pmid">16179952</pub-id></citation>
      </ref>
      <ref id="CR139">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schubert</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Anton</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Gibbs</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Norbury</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Yewdell</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Bennink</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Rapid degradation of a large fraction of newly synthesized proteins by proteasomes</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>404</volume>
          <fpage>770</fpage>
          <lpage>774</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schubert U, Anton LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770&#x2013;774 <pub-id pub-id-type="pmid">10783891</pub-id></citation>
      </ref>
      <ref id="CR140">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schweizer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fransen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Bachi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ginsel</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hauri</surname>
              <given-names>HP</given-names>
            </name>
          </person-group>
          <article-title>Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus</article-title>
          <source>J Cell Biol</source>
          <year>1988</year>
          <volume>107</volume>
          <fpage>1643</fpage>
          <lpage>1653</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schweizer A, Fransen JA, Bachi T, Ginsel L, Hauri HP (1988) Identification, by a monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular compartment at the cis-side of the Golgi apparatus. J Cell Biol 107:1643&#x2013;1653 <pub-id pub-id-type="pmid">3182932</pub-id></citation>
      </ref>
      <ref id="CR141">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Selkoe</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Folding proteins in fatal ways</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>900</fpage>
          <lpage>904</lpage>
        </citation>
        <citation citation-type="display-unstructured">Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426:900&#x2013;904 <pub-id pub-id-type="pmid">14685251</pub-id></citation>
      </ref>
      <ref id="CR142">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shults</surname>
              <given-names>CW</given-names>
            </name>
          </person-group>
          <article-title>Lewy bodies</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>1661</fpage>
          <lpage>1668</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shults CW (2006) Lewy bodies. Proc Natl Acad Sci USA 103:1661&#x2013;1668 <pub-id pub-id-type="pmid">16449387</pub-id></citation>
      </ref>
      <ref id="CR143">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sifers</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Brashears-Macatee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kidd</surname>
              <given-names>VJ</given-names>
            </name>
            <name>
              <surname>Muensch</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Woo</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum</article-title>
          <source>J Biol Chem</source>
          <year>1988</year>
          <volume>263</volume>
          <fpage>7330</fpage>
          <lpage>7335</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sifers RN, Brashears-Macatee S, Kidd VJ, Muensch H, Woo SL (1988) A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum. J Biol Chem 263:7330&#x2013;7335 <pub-id pub-id-type="pmid">3259232</pub-id></citation>
      </ref>
      <ref id="CR144">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sitia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Braakman</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Quality control in the endoplasmic reticulum protein factory</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>426</volume>
          <fpage>891</fpage>
          <lpage>894</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sitia R, Braakman I (2003) Quality control in the endoplasmic reticulum protein factory. Nature 426:891&#x2013;894 <pub-id pub-id-type="pmid">14685249</pub-id></citation>
      </ref>
      <ref id="CR145">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sohn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hur</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Joe</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Ha</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Kee</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2002</year>
          <volume>43</volume>
          <fpage>3680</fpage>
          <lpage>3685</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sohn S, Hur W, Joe MK, Kim JH, Lee ZW, Ha KS, Kee C (2002) Expression of wild-type and truncated myocilins in trabecular meshwork cells: their subcellular localizations and cytotoxicities. Invest Ophthalmol Vis Sci 43:3680&#x2013;3685 <pub-id pub-id-type="pmid">12454036</pub-id></citation>
      </ref>
      <ref id="CR146">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soto</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Unfolding the role of protein misfolding in neurodegenerative diseases</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2003</year>
          <volume>4</volume>
          <fpage>49</fpage>
          <lpage>60</lpage>
        </citation>
        <citation citation-type="display-unstructured">Soto C (2003) Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 4:49&#x2013;60 <pub-id pub-id-type="pmid">12511861</pub-id></citation>
      </ref>
      <ref id="CR147">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sousa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Parodi</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase</article-title>
          <source>EMBO J</source>
          <year>1995</year>
          <volume>14</volume>
          <fpage>4196</fpage>
          <lpage>4203</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sousa M, Parodi AJ (1995) The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. EMBO J 14:4196&#x2013;4203 <pub-id pub-id-type="pmid">7556060</pub-id></citation>
      </ref>
      <ref id="CR148">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Glucose residues as key determinants in the biosynthesis and quality control of glycoproteins with N-linked oligosaccharides</article-title>
          <source>J Biol Chem</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>35657</fpage>
          <lpage>35660</lpage>
        </citation>
        <citation citation-type="display-unstructured">Spiro RG (2000) Glucose residues as key determinants in the biosynthesis and quality control of glycoproteins with N-linked oligosaccharides. J Biol Chem 275:35657&#x2013;35660 <pub-id pub-id-type="pmid">11007802</pub-id></citation>
      </ref>
      <ref id="CR149">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swanson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Locher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hochstrasser</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation</article-title>
          <source>Gen Dev</source>
          <year>2001</year>
          <volume>15</volume>
          <fpage>2660</fpage>
          <lpage>2674</lpage>
        </citation>
        <citation citation-type="display-unstructured">Swanson R, Locher M, Hochstrasser M (2001) A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. Gen Dev 15:2660&#x2013;2674 </citation>
      </ref>
      <ref id="CR150">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szathmary</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bielmann</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Nita-Lazar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Burda</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jakob</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Yos9 protein is essential for degradation of misfolded glycoproteins and may function as lectin in ERAD</article-title>
          <source>Mol Cell</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>765</fpage>
          <lpage>775</lpage>
        </citation>
        <citation citation-type="display-unstructured">Szathmary R, Bielmann R, Nita-Lazar M, Burda P, Jakob CA (2005) Yos9 protein is essential for degradation of misfolded glycoproteins and may function as lectin in ERAD. Mol Cell 19:765&#x2013;775 <pub-id pub-id-type="pmid">16168372</pub-id></citation>
      </ref>
      <ref id="CR151">
        <citation citation-type="other">Taatjes DJ,Sobel BE, Budd RC (2008) Morphological and cytochemical determination of cell death by apoptosis. Histochem Cell Biol. doi:10.1007/s00418-007-0356-9</citation>
      </ref>
      <ref id="CR152">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamarappoo</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Verkman</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones</article-title>
          <source>J Clin Invest</source>
          <year>1998</year>
          <volume>101</volume>
          <fpage>2257</fpage>
          <lpage>2267</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tamarappoo BK, Verkman AS (1998) Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. J Clin Invest 101:2257&#x2013;2267 <pub-id pub-id-type="pmid">9593782</pub-id></citation>
      </ref>
      <ref id="CR153">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamm</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Myocilin and glaucoma: facts and ideas</article-title>
          <source>Prog Retin Eye Res</source>
          <year>2002</year>
          <volume>21</volume>
          <fpage>395</fpage>
          <lpage>428</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tamm E (2002) Myocilin and glaucoma: facts and ideas. Prog Retin Eye Res 21:395&#x2013;428 <pub-id pub-id-type="pmid">12150989</pub-id></citation>
      </ref>
      <ref id="CR154">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taxis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>ER&#x2013;Golgi traffic is a prerequisite for efficient ER degradation</article-title>
          <source>Mol Biol Cell</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>1806</fpage>
          <lpage>1818</lpage>
        </citation>
        <citation citation-type="display-unstructured">Taxis C, Vogel F, Wolf DH (2002) ER&#x2013;Golgi traffic is a prerequisite for efficient ER degradation. Mol Biol Cell 13:1806&#x2013;1818 <pub-id pub-id-type="pmid">12058050</pub-id></citation>
      </ref>
      <ref id="CR155">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teckman</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Perlmutter</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha 1-antitrypsin Z and S is distinct from that for an unassembled membrane protein</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>13215</fpage>
          <lpage>13220</lpage>
        </citation>
        <citation citation-type="display-unstructured">Teckman JH, Perlmutter DH (1996) The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha 1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J Biol Chem 271:13215&#x2013;13220 <pub-id pub-id-type="pmid">8662752</pub-id></citation>
      </ref>
      <ref id="CR156">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torossi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Sauter-Etter</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Endomannosidase processes oligosaccharides of alpha1-antitrypsin and its naturally occurring genetic variants in the Golgi apparatus</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>1923</fpage>
          <lpage>1932</lpage>
        </citation>
        <citation citation-type="display-unstructured">Torossi T, Fan JY, Sauter-Etter K, Roth J, Ziak M (2006) Endomannosidase processes oligosaccharides of alpha1-antitrypsin and its naturally occurring genetic variants in the Golgi apparatus. Cell Mol Life Sci 63:1923&#x2013;1932 <pub-id pub-id-type="pmid">16871372</pub-id></citation>
      </ref>
      <ref id="CR157">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trombetta</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Parodi</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Quality control and protein folding in the secretory pathway</article-title>
          <source>Annu Rev Cell Dev Biol</source>
          <year>2003</year>
          <volume>19</volume>
          <fpage>649</fpage>
          <lpage>676</lpage>
        </citation>
        <citation citation-type="display-unstructured">Trombetta ES, Parodi AJ (2003) Quality control and protein folding in the secretory pathway. Annu Rev Cell Dev Biol 19:649&#x2013;676 <pub-id pub-id-type="pmid">14570585</pub-id></citation>
      </ref>
      <ref id="CR158">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trombetta</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Simons</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Helenius</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a tightly bound noncatalytic HDEL-containing subunit</article-title>
          <source>J Biol Chem</source>
          <year>1996</year>
          <volume>271</volume>
          <fpage>27509</fpage>
          <lpage>27516</lpage>
        </citation>
        <citation citation-type="display-unstructured">Trombetta ES, Simons JF, Helenius A (1996) Endoplasmic reticulum glucosidase II is composed of a catalytic subunit, conserved from yeast to mammals, and a tightly bound noncatalytic HDEL-containing subunit. J Biol Chem 271:27509&#x2013;27516 <pub-id pub-id-type="pmid">8910335</pub-id></citation>
      </ref>
      <ref id="CR159">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsai</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Rapoport</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Retro-translocation of proteins from the endoplasmic reticulum into the cytosol</article-title>
          <source>Nat Rev Mol Cell Biol</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>246</fpage>
          <lpage>255</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tsai B, Ye YH, Rapoport TA (2002) Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 3:246&#x2013;255 <pub-id pub-id-type="pmid">11994744</pub-id></citation>
      </ref>
      <ref id="CR160">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turner</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Varshavsky</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Detecting and measuring cotranslational protein degradation in vivo</article-title>
          <source>Science</source>
          <year>2000</year>
          <volume>289</volume>
          <fpage>2117</fpage>
          <lpage>2120</lpage>
        </citation>
        <citation citation-type="display-unstructured">Turner GC, Varshavsky A (2000) Detecting and measuring cotranslational protein degradation in vivo. Science 289:2117&#x2013;2120 <pub-id pub-id-type="pmid">11000112</pub-id></citation>
      </ref>
      <ref id="CR161">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tveten</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Holla</surname>
              <given-names>OL</given-names>
            </name>
            <name>
              <surname>Ranheim</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Berge</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Leren</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Kulseth</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor</article-title>
          <source>FEBS J</source>
          <year>2007</year>
          <volume>274</volume>
          <fpage>1881</fpage>
          <lpage>1893</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tveten K, Holla OL, Ranheim T, Berge KE, Leren TP, Kulseth MA (2007) 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor. FEBS J 274:1881&#x2013;1893 <pub-id pub-id-type="pmid">17408384</pub-id></citation>
      </ref>
      <ref id="CR162">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Valetti</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Grossi</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Milstein</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sitia</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum</article-title>
          <source>J Cell Biol</source>
          <year>1991</year>
          <volume>115</volume>
          <fpage>983</fpage>
          <lpage>994</lpage>
        </citation>
        <citation citation-type="display-unstructured">Valetti C, Grossi CE, Milstein C, Sitia R (1991) Russell bodies: a general response of secretory cells to synthesis of a mutant immunoglobulin which can neither exit from, nor be degraded in, the endoplasmic reticulum. J Cell Biol 115:983&#x2013;994 <pub-id pub-id-type="pmid">1955467</pub-id></citation>
      </ref>
      <ref id="CR163">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vashist</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control</article-title>
          <source>J Cell Biol</source>
          <year>2004</year>
          <volume>165</volume>
          <fpage>41</fpage>
          <lpage>52</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vashist S, Ng DT (2004) Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J Cell Biol 165:41&#x2013;52 <pub-id pub-id-type="pmid">15078901</pub-id></citation>
      </ref>
      <ref id="CR164">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vashist</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Belden</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Spear</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Barlowe</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding</article-title>
          <source>J Cell Biol</source>
          <year>2001</year>
          <volume>155</volume>
          <fpage>355</fpage>
          <lpage>368</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vashist S, Kim W, Belden WJ, Spear ED, Barlowe C, Ng DT (2001) Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J Cell Biol 155:355&#x2013;368 <pub-id pub-id-type="pmid">11673477</pub-id></citation>
      </ref>
      <ref id="CR165">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vidair</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Doxsey</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Heat shock causes protein aggregation and reduced protein solubility at the centrosome and other cytosolic locations</article-title>
          <source>Int J Hyperther</source>
          <year>1966</year>
          <volume>12</volume>
          <fpage>681</fpage>
          <lpage>695</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vidair C, Huang R, Doxsey S (1966) Heat shock causes protein aggregation and reduced protein solubility at the centrosome and other cytosolic locations. Int J Hyperther 12:681&#x2013;695 </citation>
      </ref>
      <ref id="CR166">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kubo</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Kayo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Koizumi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse</article-title>
          <source>J Clin Invest</source>
          <year>1999</year>
          <volume>103</volume>
          <fpage>27</fpage>
          <lpage>37</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang J, Takeuchi T, Tanaka S, Kubo SK, Kayo T, Lu D, Takata K, Koizumi A, Izumi T (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest 103:27&#x2013;37 <pub-id pub-id-type="pmid">9884331</pub-id></citation>
      </ref>
      <ref id="CR167">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ward</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Kopito</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins</article-title>
          <source>J Biol Chem</source>
          <year>1994</year>
          <volume>269</volume>
          <fpage>25710</fpage>
          <lpage>25718</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ward CL, Kopito RR (1994) Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins. J Biol Chem 269:25710&#x2013;25718 <pub-id pub-id-type="pmid">7523390</pub-id></citation>
      </ref>
      <ref id="CR168">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Welch</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Influence of molecular and chemical chaperones on protein folding</article-title>
          <source>Cell Stress Chaperones</source>
          <year>1996</year>
          <volume>1</volume>
          <fpage>109</fpage>
          <lpage>115</lpage>
        </citation>
        <citation citation-type="display-unstructured">Welch WJ, Brown CR (1996) Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1:109&#x2013;115 <pub-id pub-id-type="pmid">9222596</pub-id></citation>
      </ref>
      <ref id="CR169">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wigley</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Fabunmi</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Muallem</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>DeMartino</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Dynamic association of proteasomal machinery with the centrosome</article-title>
          <source>J Cell Biol</source>
          <year>1999</year>
          <volume>145</volume>
          <fpage>481</fpage>
          <lpage>490</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wigley WC, Fabunmi RP, Lee MG, Marino CR, Muallem S, DeMartino GN, Thomas PJ (1999) Dynamic association of proteasomal machinery with the centrosome. J Cell Biol 145:481&#x2013;490 <pub-id pub-id-type="pmid">10225950</pub-id></citation>
      </ref>
      <ref id="CR170">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wojcik</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Schroeter</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wilk</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lamprecht</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Paweletz</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome</article-title>
          <source>Eur J Cell Biol</source>
          <year>1996</year>
          <volume>71</volume>
          <fpage>311</fpage>
          <lpage>318</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wojcik C, Schroeter D, Wilk S, Lamprecht J, Paweletz N (1996) Ubiquitin-mediated proteolysis centers in HeLa cells: indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome. Eur J Cell Biol 71:311&#x2013;318 <pub-id pub-id-type="pmid">8929570</pub-id></citation>
      </ref>
      <ref id="CR171">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolf</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Hilt</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>The proteasome: a proteolytic nanomachine of cell regulation and waste disposal</article-title>
          <source>Biochim Biophys Acta Mol Cell Res</source>
          <year>2004</year>
          <volume>1695</volume>
          <fpage>19</fpage>
          <lpage>31</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wolf DH, Hilt W (2004) The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta Mol Cell Res 1695:19&#x2013;31 </citation>
      </ref>
      <ref id="CR172">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yam</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder</article-title>
          <source>FASEB J</source>
          <year>2005</year>
          <volume>19</volume>
          <fpage>12</fpage>
          <lpage>18</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yam GH, Zuber C, Roth J (2005) A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder. FASEB J 19:12&#x2013;18 <pub-id pub-id-type="pmid">15629890</pub-id></citation>
      </ref>
      <ref id="CR173">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yam</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Bosshard</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Steinmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2006</year>
          <volume>290</volume>
          <fpage>C1076</fpage>
          <lpage>1082</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yam GH, Bosshard N, Zuber C, Steinmann B, Roth J (2006) Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants. Am J Physiol Cell Physiol 290:C1076&#x2013;1082 <pub-id pub-id-type="pmid">16531566</pub-id></citation>
      </ref>
      <ref id="CR174">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yam</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Gaplovska-Kysela</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2007</year>
          <volume>48</volume>
          <fpage>1683</fpage>
          <lpage>1690</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yam GH, Gaplovska-Kysela K, Zuber C, Roth J (2007a) Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis. Invest Ophthalmol Vis Sci 48:1683&#x2013;1690 <pub-id pub-id-type="pmid">17389500</pub-id></citation>
      </ref>
      <ref id="CR175">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yam</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Gaplovska-Kysela</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma</article-title>
          <source>Am J Pathol</source>
          <year>2007</year>
          <volume>170</volume>
          <fpage>100</fpage>
          <lpage>109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yam GH, Gaplovska-Kysela K, Zuber C, Roth J (2007b) Aggregated myocilin induces Russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol 170:100&#x2013;109 <pub-id pub-id-type="pmid">17200186</pub-id></citation>
      </ref>
      <ref id="CR176">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yam</surname>
              <given-names>GHF</given-names>
            </name>
            <name>
              <surname>GaplovskaKysela</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Aggregated myocilin induces Russell bodies and causes apoptosis&#x2013;&#x2013;implications for the pathogenesis of myocilin-caused primary open-angle glaucoma</article-title>
          <source>Am J Pathol</source>
          <year>2007</year>
          <volume>170</volume>
          <fpage>100</fpage>
          <lpage>109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yam GHF, GaplovskaKysela K, Zuber C, Roth J (2007c) Aggregated myocilin induces Russell bodies and causes apoptosis&#x2013;&#x2013;implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol 170:100&#x2013;109 <pub-id pub-id-type="pmid">17200186</pub-id></citation>
      </ref>
      <ref id="CR177">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>HH</given-names>
            </name>
            <name>
              <surname>Rapoport</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>Function of the p97&#x2013;Ufd1&#x2013;Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains</article-title>
          <source>J Cell Biol</source>
          <year>2003</year>
          <volume>162</volume>
          <fpage>71</fpage>
          <lpage>84</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ye Y, Meyer HH, Rapoport TA (2003) Function of the p97&#x2013;Ufd1&#x2013;Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 162:71&#x2013;84 <pub-id pub-id-type="pmid">12847084</pub-id></citation>
      </ref>
      <ref id="CR178">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ye</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ron</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rapoport</surname>
              <given-names>TA</given-names>
            </name>
          </person-group>
          <article-title>A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>429</volume>
          <fpage>841</fpage>
          <lpage>847</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841&#x2013;847 <pub-id pub-id-type="pmid">15215856</pub-id></citation>
      </ref>
      <ref id="CR179">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Younger</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <issue>3</issue>
          <fpage>571</fpage>
          <lpage>582</lpage>
        </citation>
        <citation citation-type="display-unstructured">Younger JM, Chen L (2006) Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell 126(3):571&#x2013;582 <pub-id pub-id-type="pmid">16901789</pub-id></citation>
      </ref>
      <ref id="CR180">
        <citation citation-type="other">Zhang K, Kaufman RJ (2006) Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb Exp Pharmacol :69&#x2013;91</citation>
      </ref>
      <ref id="CR181">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ziak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Etter</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Two isoforms of trimming glucosidase II exist in mammalian tissues and cell lines but not in yeast and insect cells</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2001</year>
          <volume>280</volume>
          <fpage>363</fpage>
          <lpage>367</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ziak M, Meier M, Etter KS, Roth J (2001) Two isoforms of trimming glucosidase II exist in mammalian tissues and cell lines but not in yeast and insect cells. Biochem Biophys Res Commun 280:363&#x2013;367 <pub-id pub-id-type="pmid">11162524</pub-id></citation>
      </ref>
      <ref id="CR182">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Guhl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Spiro</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Golgi apparatus immunolocalization of endomannosidase suggests post-endoplasmic reticulum glucose trimming: implications for quality control</article-title>
          <source>Mol Biol Cell</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>4227</fpage>
          <lpage>4240</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zuber C, Spiro MJ, Guhl B, Spiro RG, Roth J (2000) Golgi apparatus immunolocalization of endomannosidase suggests post-endoplasmic reticulum glucose trimming: implications for quality control. Mol Biol Cell 11:4227&#x2013;4240 <pub-id pub-id-type="pmid">11102520</pub-id></citation>
      </ref>
      <ref id="CR183">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Guhl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Parodi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fessler</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Immunolocalization of UDP-glucose: glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>10710</fpage>
          <lpage>10715</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zuber C, Fan JY, Guhl B, Parodi A, Fessler JH, Parker C, Roth J (2001) Immunolocalization of UDP-glucose: glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control. Proc Natl Acad Sci USA 98:10710&#x2013;10715 <pub-id pub-id-type="pmid">11535823</pub-id></citation>
      </ref>
      <ref id="CR184">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Guhl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice</article-title>
          <source>FASEB J</source>
          <year>2004</year>
          <volume>18</volume>
          <fpage>917</fpage>
          <lpage>919</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zuber C, Fan JY, Guhl B, Roth J (2004) Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice. FASEB J 18:917&#x2013;919 <pub-id pub-id-type="pmid">15033933</pub-id></citation>
      </ref>
      <ref id="CR185">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zuber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cormier</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Guhl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Santimaria</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hebert</surname>
              <given-names>DN</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>4407</fpage>
          <lpage>4412</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zuber C, Cormier JH, Guhl B, Santimaria R, Hebert DN, Roth J (2007) EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites. Proc Natl Acad Sci USA 104:4407&#x2013;4412 <pub-id pub-id-type="pmid">17360537</pub-id></citation>
      </ref>
      <ref id="CR186">
        <citation citation-type="other">Zwickl P, Seemuller E, Kapelari B, Baumeister W (2002) The proteasome: a supramolecular assembly designed for controlled proteolysis. In: Richards FM, Eisenberg DS, Kuriyan J (eds) Protein folding in the cell, vol 59. Academic Press Inc., San Diego, pp 187&#x2013;222</citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>